"Rank","NCT Number","Title","Status","Study Results","Conditions","Interventions","First Posted","Locations","URL"
1,"NCT04386187","Glutathione-rich Foods for Type 2 Diabetes","Not yet recruiting","No Results Available","Type 2 Diabetes","Other: GSH Foods|Other: Nutrition education about glutathione sources in the diet|Other: Standard of care nutrition education for type 2 dabetes","May 13, 2020",,"https://ClinicalTrials.gov/show/NCT04386187"
2,"NCT04259489","Effectiveness of SCDM in Patients With Type 2 Diabetes","Not yet recruiting","No Results Available","Type 2 Diabetes","Behavioral: Shared Care diabetes management","February 6, 2020","Beijing Chao-Yang Hospital, Capital Medical University, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT04259489"
3,"NCT04427488","The Effect of Exercises Performed According to Circadian Rhythm in Type 2 Diabetes","Active, not recruiting","No Results Available","Type 2 Diabetes","Other: Aerobic Exercises According to Circadian Rhythym|Other: Strengthening Exercises According to Circadian Rhythym","June 11, 2020","Istanbul Medipol University, Istanbul, Turkey","https://ClinicalTrials.gov/show/NCT04427488"
4,"NCT04403217","Effect of MEDiterranean Diet on the microBIOME of Individuals With Type 2 Diabetes","Recruiting","No Results Available","Type 2 Diabetes","Other: Individualized structured dietary plan based on MD","May 27, 2020","NOVA Medical School Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisbon, Portugal","https://ClinicalTrials.gov/show/NCT04403217"
5,"NCT04315519","Effect of Blood Flow Restricted Aerobic Exercise in Type 2 Diabetes Mellitus","Not yet recruiting","No Results Available","Type 2 Diabetes","Other: Exercise","March 19, 2020",,"https://ClinicalTrials.gov/show/NCT04315519"
6,"NCT04403841","Effect of Group Patient Education on Glycemic Control Among People Living With Type 2 Diabetes in Vietnam","Completed","No Results Available","Type 2 Diabetes","Other: patient education and self-management intervention in a low-resource setting on diabetes knowledge and levels of blood glucose control|Other: Usual diabetes care alone","May 27, 2020","Hanoi Medical University, Hanoi, Vietnam","https://ClinicalTrials.gov/show/NCT04403841"
7,"NCT04363710","Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet","Completed","No Results Available","Type 2 Diabetes Mellitus in Obese","Other: Low Calorie Diet","April 27, 2020","Max Healthcare, New Delhi, Delhi, India","https://ClinicalTrials.gov/show/NCT04363710"
8,"NCT04287387","Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents","Not yet recruiting","No Results Available","Type2 Diabetes Mellitus","Drug: Glucophage 500Mg Tablet|Drug: Acarbose Tablets|Drug: Sitagliptin tablet|Drug: Dapagliflozin Tablet|Drug: Pioglitazone Tablets|Drug: Glimepiride Tablets","February 27, 2020","Peking Union Medical College Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT04287387"
9,"NCT04264793","Skills for Change: Nutrition Education Program for Emirati Adults With Type 2 Diabetes","Completed","No Results Available","Type 2 Diabetes","Behavioral: Behavioral Lifestyle Intervention|Behavioral: Usual Care","February 11, 2020","Ambulatory Healthcare Services, SEHA, Al Ain, United Arab Emirates","https://ClinicalTrials.gov/show/NCT04264793"
10,"NCT04228484","The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes","Recruiting","No Results Available","Type2 Diabetes","Drug: Insulin|Drug: Empagliflozin|Drug: Metformin","January 14, 2020","Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup, Capital Region, Denmark","https://ClinicalTrials.gov/show/NCT04228484"
11,"NCT04383639","Cocoa/Carob Polyphenols and Postprandial Changes in Type 2 Diabetes","Not yet recruiting","No Results Available","Type 2 Diabetes","Other: No product (A)/mixture of coca and carob together with breakfast (B)/mixture of coca and carob 10 h before breakfast (C)","May 12, 2020","Institute of Food Science, Technology and Nutrition, National Research Council (ICTAN-CSIC), Madrid, Spain","https://ClinicalTrials.gov/show/NCT04383639"
12,"NCT04221399","Type 2 Diabetes Patients With Renal Impairment","Not yet recruiting","No Results Available","Type2 Diabetes","Drug: DWP16001","January 9, 2020",,"https://ClinicalTrials.gov/show/NCT04221399"
13,"NCT04419779","Evaluation of the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita™ System in Subjects With Type 2 Diabetes on Insulin Therapy","Not yet recruiting","No Results Available","Type 2 Diabetes","Device: Duodenal Mucosal Resurfacing (DMR)|Device: Duodenal Mucosal Resurfacing (Sham)","June 5, 2020",,"https://ClinicalTrials.gov/show/NCT04419779"
14,"NCT04369664","CHOlesterol Lowering and Residual Risk in Type 2 Diabetes","Recruiting","No Results Available","Type 2 Diabetes","Drug: Statin|Drug: PCSK9 inhibitor","April 30, 2020","NYU Langone Health, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04369664"
15,"NCT04298970","Novel Organic Kale Products for Prevention of Obesity/Type 2 Diabetes","Active, not recruiting","No Results Available","Type2 Diabetes","Dietary Supplement: Intervention|Dietary Supplement: Placebo","March 6, 2020","Aarhus University, Aarhus C, Denmark","https://ClinicalTrials.gov/show/NCT04298970"
16,"NCT04266171","Precision Nutrition Counseling in Type 2 Diabetes Patients","Recruiting","No Results Available","Type 2 Diabetes","Behavioral: Diet education based on CGMS data|Behavioral: Conventional diet education","February 12, 2020","Seoul National University Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04266171"
17,"NCT04296825","Effect of Camel Milk With Probiotic on Type 2 Diabetes Mellitus","Completed","No Results Available","Type 2 Diabetes","Dietary Supplement: Camel milk containing Bifidobacterium animalis A6|Dietary Supplement: Camel milk|Dietary Supplement: Bifidobacterium animalis A6|Dietary Supplement: Cow milk","March 5, 2020","Beijing Chinese Medicine Hospital Pinggu Hospital, Beijing, China","https://ClinicalTrials.gov/show/NCT04296825"
18,"NCT04219124","The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes","Recruiting","No Results Available","Type 2 Diabetes","Drug: IMP oral tablet|Drug: Placebo oral tablet","January 6, 2020","CEDAR, Royal Surrey County Hospital, Guildford, Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT04219124"
19,"NCT04331444","Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes.","Not yet recruiting","No Results Available","Type 2 Diabetes Treated With Insulin","Device: CGM|Behavioral: training course|Behavioral: Peer-support","April 2, 2020",,"https://ClinicalTrials.gov/show/NCT04331444"
20,"NCT04426422","Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes","Completed","No Results Available","Type 2 Diabetes","Drug: Metformin Hydrochloride","June 11, 2020","Shenzhen People' S Hospital, Shenzhen, Guangdong, China","https://ClinicalTrials.gov/show/NCT04426422"
21,"NCT04279444","Effects of BKR-017 on Insulin Resistance in Type 2 Diabetes Patients","Not yet recruiting","No Results Available","Type 2 Diabetes","Dietary Supplement: BKR-017","February 21, 2020","Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States","https://ClinicalTrials.gov/show/NCT04279444"
22,"NCT04373967","Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes","Not yet recruiting","No Results Available","Type 2 Diabetes","Drug: Victoza®.|Drug: Metformin Hydrochloride|Drug: TQZ2451","May 5, 2020","Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China","https://ClinicalTrials.gov/show/NCT04373967"
23,"NCT04245267","Multicomponent Integrated Intervention on Metabolic Control and Quality of Life in Type 2 Diabetes: DIABEMPIC Program","Recruiting","No Results Available","Type 2 Diabetes","Behavioral: DIABEMPIC","January 28, 2020","Clínica Especializada en el Manejo de la Diabetes de la Ciudad de México from the Ministry of Health of the Mexico City Government, Mexico City, Iztapalapa, Mexico","https://ClinicalTrials.gov/show/NCT04245267"
24,"NCT04219215","Acute Hyperbaric Oxygen (HBO) Treatment Increases Hepatic Insulin Sensitivity and Muscle Reactive Oxygen Species in Type 2 Diabetes","Recruiting","No Results Available","Type 2-diabetes","Device: hyperbaric oxygen chamber","January 6, 2020","German Diabetes Center, Duesseldorf, NRW, Germany","https://ClinicalTrials.gov/show/NCT04219215"
25,"NCT04222231","RESIST! Blood-flow Restriction Resistance Training for Improving Insulin Sensitivity in Type 2 Diabetes","Enrolling by invitation","No Results Available","Type 2 Diabetes","Other: Blood-flow restriction resistance training|Other: Classical resistance training","January 9, 2020","German Diabetes Center, Düsseldorf, NRW, Germany","https://ClinicalTrials.gov/show/NCT04222231"
26,"NCT04356742","Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control","Not yet recruiting","No Results Available","Type 2 Diabetes","Drug: Dapagliflozin 10mg|Drug: Placebo|Drug: Evogliptin 5mg|Drug: Metformin≥1000mg","April 22, 2020","The Catholic University of Korea Bucheon St. Mary's Hospital, Bucheon, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04356742"
27,"NCT04432025","Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus","Not yet recruiting","No Results Available","Obesity|Type 2 Diabetes","Procedure: Bariatric surgery + goal directed medical therapy|Procedure: Bariatric surgery","June 16, 2020",,"https://ClinicalTrials.gov/show/NCT04432025"
28,"NCT04441658","Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus","Recruiting","No Results Available","Type 2 Diabetes|Mesenchymal Stem Cells","Biological: Umbilical Cord Mesenchymal Stem Cells|Biological: saline","June 22, 2020","Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04441658"
29,"NCT04345120","Multiple Ascending Doses of SY-008 in Type 2 Diabetes Mellitus","Not yet recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: SY-008|Drug: SY-008 matching placebo","April 14, 2020",,"https://ClinicalTrials.gov/show/NCT04345120"
30,"NCT04345107","Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus","Not yet recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: SY-009|Drug: SY-009 matching placebo","April 14, 2020",,"https://ClinicalTrials.gov/show/NCT04345107"
31,"NCT04217291","The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus","Recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: SY-004|Other: SY-004 matching placebo","January 3, 2020","PLA General Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT04217291"
32,"NCT04313829","Pharmacist Counseling on the Health-related Quality of Life of Patients With Type 2 Diabetes Mellitus","Completed","No Results Available","Type 2 Diabetes Mellitus","Behavioral: Pharmacist Counseling Intervention","March 18, 2020","Puskesmas Antang, Makassar, South Sulawesi, Indonesia|Puskesmas Batua, Makassar, South Sulawesi, Indonesia|Puskesmas Jongaya, Makassar, South Sulawesi, Indonesia|Puskesmas Tamalanrea, Makassar, South Sulawesi, Indonesia","https://ClinicalTrials.gov/show/NCT04313829"
33,"NCT04255433","A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes","Recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: Tirzepatide|Drug: Dulaglutide","February 5, 2020","University of Alabama at Birmingham Medical, Birmingham, Alabama, United States|John Muir Physician Network Clinical Research Center, Concord, California, United States|Valley Clinical Trials, Inc., Covina, California, United States|AMCR Institute INC, Escondido, California, United States|Valley Endocrine, Fresno, Fresno, California, United States|Marin Endocrine Associates, Greenbrae, California, United States|UCSD Clinical & Translational Research Institute, La Jolla, California, United States|Diabetes and Endocrine Associates, La Mesa, California, United States|First Valley Medical Group, Lancaster, California, United States|Monterey Endocrine & Diabetes Institute, Inc., Monterey, California, United States|Riverside County Regional Medical Center, Moreno Valley, California, United States|Valley Clinical Trials, Inc., Northridge, California, United States|Diabetes Associates Medical Group, Orange, California, United States|Riverside Cardiology Associates, Riverside, California, United States|LCGK Research, San Carlos, California, United States|NorCal Endocrinology and Internal Medicine - Roseville, San Ramon, California, United States|Harbor UCLA Medical Center, Torrance, California, United States|Coastal Metabolic Research Centre, Ventura, California, United States|Veteran's Affairs Medical Center, Aurora, Colorado, United States|Bridgeport Hosptial, Bridgeport, Connecticut, United States|CMR of Greater New Haven, LLC, Hamden, Connecticut, United States|Chase Medical Research, LLC, Waterbury, Connecticut, United States|Orlando Heart & Vascular Institute, LLC, Altamonte Springs, Florida, United States|Excel Medical Clinical Trials, LLC, Boca Raton, Florida, United States|East Coast Institute For Research, Jacksonville, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Ocala Cardiovascular Research, Ocala, Florida, United States|Cardiology Partners Clinical Research Institute, LLC-Palm Beach Gardens, Palm Beach Gardens, Florida, United States|Charlotte Heart & Vascular Institute, Port Charlotte, Florida, United States|Meridien Research, Saint Petersburg, Florida, United States|Professional Health Care of Pinellas, Saint Petersburg, Florida, United States|Cardiology Partners Clinical Research Institute, LLC, Wellington, Florida, United States|Clinical Research of Central Florida, Winter Haven, Florida, United States|Atlanta Diabetes Associates, Atlanta, Georgia, United States|Ellipsis Group, Atlanta, Georgia, United States|Atlanta Heart Specialist, Cumming, Georgia, United States|Kaiser Permanente - Dutluth, GA, Duluth, Georgia, United States|Physicians Research Associates, LLC, Lawrenceville, Georgia, United States|East Coast Institute For Research, Macon, Georgia, United States|Fellows Research Alliance, Inc, Savannah, Georgia, United States|Atlanta Heart Specialists, Tucker, Georgia, United States|East West Medical Institute, Honolulu, Hawaii, United States|PHREI - Pacific Health Research and Education Institute - VA Pacific Islands Health Care System, Honolulu, Hawaii, United States|Elite Clinical Trials LLLP, Blackfoot, Idaho, United States|Idaho State University, Pocatello, Idaho, United States|Northwest Heart Clinical Research, LLC, Arlington Heights, Illinois, United States|Cedar-Crosse Research Center, Chicago, Illinois, United States|Clinical Investigation Specialists Inc, Gurnee, Illinois, United States|Springfield Diabetes & Endocrine Center, Springfield, Illinois, United States|University of Iowa Hospital & Clinic, Iowa City, Iowa, United States|Iowa Diabetes Research, West Des Moines, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Cotton O'Neil Clinic, Topeka, Kansas, United States|Cotton O'Neil Diabetes and Endocrinology Center, Topeka, Kansas, United States|Qualmedica Research LLC, Bowling Green, Kentucky, United States|Kentucky Diabetes Endocrinology Center, Lexington, Kentucky, United States|L-Marc Research Center, Louisville, Kentucky, United States|Qualmedica Research LLC, Owensboro, Kentucky, United States|Alexandria Cardiology Clinic, Alexandria, Louisiana, United States|Maryland Cardiovascular Specialists, Baltimore, Maryland, United States|MedStar Health Research Institute, Hyattsville, Maryland, United States|Ong Medical Center, Oxon Hill, Maryland, United States|Endocrine and Metabolic Consultants, Rockville, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Joslin Diabetes Center, Boston, Massachusetts, United States|ActivMed Practices & Research, Inc, Methuen, Massachusetts, United States|Infinity Medical Research, North Dartmouth, Massachusetts, United States|Grunberger Diabetes Institute, Bloomfield Hills, Michigan, United States|Troy Internal Medicine, PC, Troy, Michigan, United States|St Cloud Hospital/Central Minnesota Heart Center, Saint Cloud, Minnesota, United States|HealthEast Medical Research Institute, Saint Paul, Minnesota, United States|Mercy Research Diabetes, Saint Louis, Missouri, United States|StudyMetrix Research, LLC, Saint Peters, Missouri, United States|Mercy Medical Research Institute, Springfield, Missouri, United States|Clinvest Research LLC, Springfield, Missouri, United States|Billings Clinic, Billings, Montana, United States|Mercury Street Medical Group, PLLC, Butte, Montana, United States|Great Falls Clinic - Clinical Research, Great Falls, Montana, United States|Omaha VA Medical Center, Omaha, Nebraska, United States|University of Nebraska- Medical Center, Omaha, Nebraska, United States|Palm Research Center, Las Vegas, Nevada, United States|Palm Research Center, Las Vegas, Nevada, United States|Southern New Hampshire Diabetes and Endocrinology, Nashua, New Hampshire, United States|Cardiovascular Associates of the Delaware Valley, Haddon Heights, New Jersey, United States|Endocrine Group, LLP, Albany, New York, United States|Great Lakes Medical Research, Westfield, New York, United States|Atrium Health - Department of Family Medicine Research, Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|PMG Research Mooresville, LLC, Mooresville, North Carolina, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, United States|Lillestol Research LLC, Fargo, North Dakota, United States|Cleveland Clinic, Cleveland, Ohio, United States|Heritage Valley Medical Group, Inc., Beaver, Pennsylvania, United States|Capital Area Research, Camp Hill, Pennsylvania, United States|Diabetes & Endocrinology Consultants of Pennsylvania, LLC, Feasterville, Pennsylvania, United States|Detweiler Family Medicine, Lansdale, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Northeast Endocrine Metabolic Associates, Philadelphia, Pennsylvania, United States|Preferred Primary Care Physicians, Pittsburgh, Pennsylvania, United States|Geisinger Community Medical Center, Scranton, Pennsylvania, United States|Mountain View Clinical Research, Inc., Greer, South Carolina, United States|PMG Research of Charleston, LLC, Mount Pleasant, South Carolina, United States|Black Hills Cardiovascular Research Group, Rapid City, South Dakota, United States|Holston Medical Group, Bristol, Tennessee, United States|PMG Research of Knoxville, Knoxville, Tennessee, United States|Endocrine Clinic, Memphis, Tennessee, United States|Office of Dr. Osvaldo Brusco, Corpus Christi, Texas, United States|Dallas Diabetes Endocrine Center, Dallas, Texas, United States|Cardiovascular Research Institute of Dallas, Dallas, Texas, United States|North Texas Endocrine Center, Dallas, Texas, United States|Research Institute of Dallas, PA, Dallas, Texas, United States|Galenos Research, Dallas, Texas, United States|Academy Of Diabetes Thyroid & Endocrine, El Paso, Texas, United States|Diabetes and Thyroid Center of Fort Worth, Fort Worth, Texas, United States|Horizon Clinical Research Group, Houston, Texas, United States|Southern Endocrinology and Associates PA, Mesquite, Texas, United States|North Hills Medical Research, North Richland Hills, Texas, United States|South Texas Veterans Administration Health Care, San Antonio, Texas, United States|Consano Clinical Research, Shavano Park, Texas, United States|Northwest Houston Heart Center, Tomball, Texas, United States|Physicians' Research Options, LLC, Draper, Utah, United States|Advanced Research Institute, Ogden, Utah, United States|Wasatch Clinical Research, LLC, Salt Lake City, Utah, United States|Virginia Heart, Falls Church, Virginia, United States|McGuire VA Medical Center, Richmond, Virginia, United States|VA Puget Sound Health Care System, Seattle, Washington, United States|Rockwood Clinic Research Center, Spokane, Washington, United States|Multicare Health System, Tacoma, Washington, United States|Wenatchee Valley Hospital & Clinics, Wenatchee, Washington, United States|Clinical Investigation Specialists Inc, Kenosha, Wisconsin, United States|Instituto de Investigaciones Clínicas Bahía Blanca (IIC Bahia Blanca), Bahía Blanca, Buenos Aires, Argentina|Stat Research, Caba, Buenos Aires, Argentina|Centro OMI, Caba, Buenos Aires, Argentina|Centro de Investigaciones Metabólicas (CINME), Caba, Buenos Aires, Argentina|Mautalen Salud e Investigación - Servicio de Endocrinología, Caba, Buenos Aires, Argentina|Centro Medico Dr Laura Maffei Investigacion Clinica Aplicada, Caba, Buenos Aires, Argentina|CEDIC-Centro de Investigaciones Clinicas, Caba, Buenos Aires, Argentina|Glenny Corp SA- BIOCLINICA Argentina, Caba, Buenos Aires, Argentina|CEMEDIC, Caba, Buenos Aires, Argentina|Centro de Investigacion y Prevencion Cardiovascular (CIPREC), Ciudad Autonoma de, Buenos Aires, Argentina|Instituto de Investigaciones Clinicas Mar del Plata, Mar del Plata, Buenos Aires, Argentina|DIM Clinica Privada, Ramos Mejía, Buenos Aires, Argentina|GO Centro Médico San Nicolás, San Nicolás, Buenos Aires, Argentina|Instituto de Investigaciones Clinicas Zarate, Zarate, Buenos Aires, Argentina|Instituto de Investigaciones Clínicas Rosario (IIC-Rosario)- Sanatorio Delta, Rosario, Santa Fe, Argentina|Instituto Médico Catamarca, Rosario, Santa Fe, Argentina|Grupo Colaborativo Rosario, Rosario, Santa Fe, Argentina|Clínica Mayo, San Miguel de Tucuman, Tucuman, Argentina|Centro Privado de Cardiologia Investigaciones Clinicas Tucum, San Miguel de Tucuman, TUC, Argentina|Centro Médico Viamonte, Ciudad Autonoma de Buenos Aire, Argentina|Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff, Ciudad Autonoma de Buenos Aire, Argentina|Hospital Sirio Libanes, Ciudad Autonoma de Buenos Aire, Argentina|Centro Diabetologico Dr Waitman, Cordoba, Argentina|CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani, Cordoba, Argentina|Centro Medico Privado San Vicente Diabetes, Cordoba, Argentina|Cent Priva Especiali Médicas Ambulatorias Inve Clin CEMAIC, Cordoba, Argentina|Centro Universitario de Investigaciones en Farmacologia Clinica (CUIFC), Corrientes, Argentina|Instituto de cardiologia de Corrientes ""Juana Cabral"", Corrientes, Argentina|Sanatorio Parque Salta, Salta, Argentina|Sanatorio Norte, Santiago del Estero, Argentina|Centro Medico Privado de Reumatologia, Tucuman, Argentina|Boden Collaboration for Obesity, Nutrition, Exercise & Eating Disorders, Camperdown, New South Wales, Australia|Nepean Family Metabolic Health Service, Kingswood, New South Wales, Australia|The AIM Centre, Merewether, New South Wales, Australia|Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia|CORE Research Group Pty Ltd, Brisbane, Queensland, Australia|The Townsville Hospital, Douglas, Queensland, Australia|Royal Brisbane and Womens Hospital, Herston, Queensland, Australia|Mater Adult Hospital Brisbane, South Brisbane, Queensland, Australia|Gold Coast University Hospital, Southport, Queensland, Australia|Heart and Vascular Institute, Adelaide, South Australia, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|GP Plus Marion, Oaklands Park, South Australia, Australia|Launceston General Hospital, Launceston, Tasmania, Australia|Eastern Clinical Research Unit, Box Hill, Victoria, Australia|Monash Cardiovascular Research Centre, Clayton, Victoria, Australia|Barwon Health - The Geelong Hospital, Geelong, Victoria, Australia|Austin Health - Heidelberg Repatriation Hospital, Heidelberg Heights, Victoria, Australia|Fremantle Hospital, Fremantle, Western Australia, Australia|GenesisCare Joondalup WA, Joondalup, Western Australia, Australia|GenesisCare - Wexford Medical Centre WA, Murdoch, Western Australia, Australia|Universitätsklinikum Graz, Graz, Steiermark, Austria|Universitätsklinikum Salzburg, Salzburg, Austria|KA Rudolfstiftung, Wien, Austria|Zentrum für klinische Studien Dr. Ursula Hanusch GmbH, Wien, Austria|AKH, Wien, Austria|KH Hietzing mit neurologischem Zentrum Rosenhügel, Wien, Austria|AZ Klina, Brasschaat, Antwerp, Belgium|AZ Nikolaas, Campus Moerland, Sint-Niklaas, Oost-Vlaanderen, Belgium|AZ Delta, Roeselare, West Flanders, Belgium|Onze Lieve Vrouwe ZKHS Aalst, Aalst, Belgium|Imeldaziekenhuis, Bonheiden, Belgium|AZ Sint-Jan AV, Brugge, Belgium|ULB Erasme, Brussels, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, Belgium|UZ Brussel, Jette, Belgium|AZ Groeninge, Kortrijk, Belgium|Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium|CHU de Liège, Liege, Belgium|Jan Palfijn Ziekenhuis, Merksem, Belgium|AZ Damiaan Oostende, Oostende, Belgium|Centro de Pesq. em Diabetes e Doencas Endocrino Metabol., Fortaleza, Ceará, Brazil|Cedoes Centro Diagnostico Pequisa Osteoporose E Santo Ltd, Vitoria, ES, Brazil|QUANTA - Medicina Nuclear Alto da XV, Curitiba, Paraná, Brazil|Centro de Pesquisas em Diabetes, Porto Alegre, Rio Grande Do Sul, Brazil|Loema - Instituto de Pesquisa Clinica, Campinas, SP, Brazil|CPQuali Pesquisa Clínica Ltda., São Paulo, SP, Brazil|Cpclin Centro de Pesquisas Clinicas, São Paulo, SP, Brazil|CEPIC-Centro Paulista de Investigacao Clinica, São Paulo, SP, Brazil|Hospital da Clinicas da Faculdade de Medicina da USP, São Paulo, SP, Brazil|IPECC - Instituto de Pesquisa Clinica de Campinas, Campinas, São Paulo, Brazil|Faculdade de Medicina do ABC - CEPES, Santo André, São Paulo, Brazil|Instituto Brasil de Pesquisa Clínica - IBPCLIN, Rio de Janeiro, Brazil|IPEC - Instituto de Pesquisa Clínica, São Paulo, Brazil|LMC Manna Research, Calgary, Alberta, Canada|Dr. T.G. Elliott, Inc., Vancouver, British Columbia, Canada|Dr. M.B. Jones Inc., Victoria, British Columbia, Canada|Winnipeg Clinic, Winnipeg, Manitoba, Canada|Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada|LMC Endocrinology Centres Ltd., Barrie, Ontario, Canada|LMC Endocrinology Centers Brampton, Brampton, Ontario, Canada|Aggarwal and Associates Ltd, Brampton, Ontario, Canada|Cambridge Cardiac Care Centre, Cambridge, Ontario, Canada|LMC Endocrinology Centres Ltd., Concord, Ontario, Canada|LMC Endocrinology Centres Ltd., Etobicoke, Ontario, Canada|Hamilton General Hospital Divison, Hamilton, Ontario, Canada|Milestone Research Inc., London, Ontario, Canada|St Joseph Health Care, London, Ontario, Canada|LMC Endocrinology Centres Ltd., Nepean, Ontario, Canada|LMC Endocrinology Centres, Oakville, Ontario, Canada|Oshawa Medical Arts Building, Oshawa, Ontario, Canada|Kawartha Cardiology Clinical Trials, Peterborough, Ontario, Canada|Bluewater Clinical Research Group Inc, Sarnia, Ontario, Canada|Canadian Centre for Research on Diabetes, Smiths Falls, Ontario, Canada|Janik Research Corporation, Sudbury, Ontario, Canada|Canadian Phase Onward Inc, Toronto, Ontario, Canada|LMC Endocrinology Centres Ltd., Toronto, Ontario, Canada|Diabetes Heart Research Center, Toronto, Ontario, Canada|ViaCar Recherche Clinique, Greenfield Park, Quebec, Canada|Centre De Recherche Clinique De Laval, Laval, Quebec, Canada|Manna Research (Quebec), Levis, Quebec, Canada|Clinique Santé Cardio MC, Montreal, Quebec, Canada|CR A&E Centre de Recherche Inc., Quebec City, Quebec, Canada|Peking University Peoples Hospital, Beijing, Beijing, China|The First Affiliated Hospital of Lanzhou University, Lanzhou, Gansu, China|The First Affiliated Hospital, Sun-Yat Sen University, Guangzhou, Guangdong, China|The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China|Xiangya Hospital, Central South University, Changsha, Hunan, China|The First Hospital of Nanjing, Nanjing, Jiangsu, China|Nanjing Drum Tower Hosp Affiliated Hosp of Nanjing Univ Med, Nanjing, Jiangsu, China|Zhongda Hospital Southeast University, Nanjing, Jiangsu, China|The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China|Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China|The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China|People's Hospital of Liaoning Province, Shenyang, Liaoning, China|General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China|The First Afflicated Hospital of Xian Jiaotong University, Xian, Shan XI, China|Jinan Central Hospital, Jinan, Shandong, China|Beijing Anzhen Hospital, Beijing, China|China-Japan Friendship Hospital, Beijing, China|Peking University First Hospital, Beijing, China|Peking University First Hospital, Beijing, China|Beijing Friendship Hospital Affiliate of Capital University, Beijing, China|People's Hospital of Hunan Province, Changsha, China|Tianjin Medical University General Hospital, Tianjin, China|Diacentrum Brandys n.L. s.r.o., Brandys Nad Labem-Stara Bolesl, Czechia|Diabetologicka a obezitologicka ambulance, Ceske Budejovice, Czechia|Diabetologicka ordinace pro dospele, Krnov, Czechia|Interni a diabetologicka ordinace, s.r.o., Nachod, Czechia|Diabet2 s.r.o., Diabetologicka a interni ambulance, Praha 1, Czechia|LF UK - Fakultni poliklinika, Praha 2, Czechia|MUDr. Michala Pelikanova s.r.o., Praha 4, Czechia|Milan Kvapil s.r.o., Praha 4, Czechia|RESTRIAL s.r.o., Praha 8, Czechia|MUDr. Barbora Diepoltova, Diabetologie Praha 9, Praha 9, Czechia|Hopital G et R Laennec, Nantes, Cedex 01, France|Hopital Bichat Claude Bernard, Paris, Cedex 18, France|CHU Toulouse Hopital de Rangueil, Toulouse, Cedex 9, France|Centre Hospitalier Sud Francilien, Corbeil-Essonne, France|CHU De Dijon Hopital Du Bocage, Dijon Cedex, France|Clinique Hotel Dieu, Le Creusot, France|Groupe Hospitalier Paris Saint Joseph - Site Saint-Michel, Paris Cedex 14, France|Hopital Lariboisière, Paris, France|CHU de Bordeaux, Hopital du Haut Leveque, service endocrinologie diabetologie nutrition, Pessac Cedex, France|CHU Brabois, Vandoeuvre Les Nancy, France|Groupe hospitalier mutualiste Les Portes du sud, Venissieux, France|Diabetesinstitut am St. Josefskrankenhaus, Heidelberg, Baden-Württemberg, Germany|Internistische Gemeinschaftspraxis Jünemann, Dr. med. Stübler, Mannheim, Baden-Württemberg, Germany|Marienhospital Stuttgart, Stuttgart, Baden-Württemberg, Germany|Praxis für Prävention und Therapie, Villingen-Schwenningen, Baden-Württemberg, Germany|Praxis Dr. med. Joachim Sauter, Wangen im Allgäu, Baden-Württemberg, Germany|Centrum für Diagnostik und Gesundheit - Studienambulanz Dr. Hartard, Munchen, Bavaria, Germany|LMU Klinikium, Munich, Bavaria, Germany|Studienzentrum, Aschaffenburg, Bayern, Germany|Praxis Dr. med. Ilka Simon-Wagner, Lichtenfels, Bayern, Germany|Praxis Dr. Jörg Lüdemann, Falkensee, Brandenburg, Germany|Diabetes Zentrum Dr. Tews, Gelnhausen, Hessen, Germany|Arztpraxis Dr. Cornelia Marck, Pohlheim, Hessen, Germany|Diabetologische Schwerpunktpraxis, Lüneburg, Niedersachsen, Germany|Universitätsklinikum Bochum, Bad Oeynhausen, Nordrhein-Westfalen, Germany|St Josef-Hospital Bochum, Bochum, Nordrhein-Westfalen, Germany|Praxis Bonnermann/Lorra, Bochum, Nordrhein-Westfalen, Germany|Diabeteszentrum DO, Diabetische Schwerpunktpraxis Dortmund, Dortmund, Nordrhein-Westfalen, Germany|InnoDiab Forschung GmbH, Essen, Nordrhein-Westfalen, Germany|Medizentrum Essen-Borbeck, Essen, Nordrhein-Westfalen, Germany|Praxis Becker, Essen, Nordrhein-Westfalen, Germany|Institut für Diabetesforschung Münster GmbH, Münster, Nordrhein-Westfalen, Germany|Deutsches Diabetes-Zentrum (DDZ), Düsseldorf, North Rhine-Westphalia, Germany|Praxis Dr. Kempe - Dr. Stemler, Ludwigshafen am Rhein, Rheinland-Pfalz, Germany|Praxis Dr. Segiet, Speyer, Rheinland-Pfalz, Germany|Gemeinschaftspraxis Dres. Denger&Pfitzner, Friedrichsthal, Saarland, Germany|Praxis Dr. V. Wenzl-Bauer, Rehlingen-Siersburg, Saarland, Germany|Schwerpunktpraxis Diabetes, Saint Ingbert-Oberwürzbach, Saarland, Germany|Hausarzt-Diabetologische Schwerpunktpraxis Dr. Karsten Milek, Hohenmölsen, Sachsen-Anhalt, Germany|SMO.MD GmbH, Magdeburg, Sachsen-Anhalt, Germany|AmBeNet, Leipzig, Sachsen, Germany|Diabetologische Schwerpunktpraxis Dr. Christine Kosch, Pirna, Sachsen, Germany|MVZ Riesa, Medizinisches Versorgungzentrum am Klinikum Döbel, Riesa, Sachsen, Germany|Cardiologicum Dresden und Pirna, Dresden, Saxony, Germany|Universitätsstudienzentrum für Stoffwechselerkrankungen, Dresden, Saxony, Germany|SIBAmed Studienzentrum GmbH & Co. KG, Leipzig, Saxony, Germany|Universität Leipzig - Universitätsklinikum, Leipzig, Saxony, Germany|Gemeinschaftspraxis Dr.Täschner/Dr. Bonigut, Leipzig, Saxony, Germany|Praxis für Innere Medizin Toralf Schwarz, Zwenkau, Saxony, Germany|Universitätsklinikum Schleswig-Holstein, Lübeck, Schleswig-Holstein, Germany|RED-Institut GmbH, Oldenburg, Schleswig-Holstein, Germany|Praxis Dr. Karin Schlecht, Eisenach, Thüringen, Germany|Diabetespraxis Prenzlauer Allee, Berlin, Germany|Institut für klinische Forschung und Entwicklung, Berlin, Germany|Dres. Jung Gemeinschaftspraxis, Deggingen, Germany|Zentrum für Klinische Studien Südbrandenburg GmbH, Elsterwerda, Germany|MVZ im Altstadt-Carree Fulda GmbH, Fulda, Germany|Diabetologische Schwerpunktpraxis B. Scholz/Dr. B. Paschen, Hamburg, Germany|Diabetes-Zentrum Wilhelmsburg, Hamburg, Germany|Gemeinschaftspraxis für innere Medizin und Diabetologie, Hamburg, Germany|Iatriko Palaiou Falirou, Medical Center, Palaio Faliro, Athens, Greece|Gen Hospital of Athens G Gennimatas, Athens, Attiki, Greece|General Hospital of Thessaloniki Papageorgiou, N. Efkarpia, Thessaloniki, Greece|Thermi Clinic, Thermi, Thessaloniki, Greece|Athens Euroclinic, Athens, Greece|Attikon' University Hospital, Haidari/Athens, Greece|University General Hospital of Larissa, Larissa, Greece|AHEPA Hospital, Thessaloniki, Greece|Ippokrateio General Hospital of Thessaloniki, Thessaloniki, Greece|Euromedica - General Clinic of Thessaloniki, Thessaloniki, Greece|Studium Egeszseghaz Kft., Kalocsa, Bacs-Kiskun, Hungary|Zsigmondy Vilmos Harkanyi Gyogyfurdokorhaz, Harkany, Baranya, Hungary|DRC Gyogyszervizsgalo Rendelointezet Kft, Balatonfüred, EU, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Szekesfehervar, Fejer, Hungary|Kenezy Gyula Korhaz es Rendelointezet, Debrecen, Hajdu-Bihar, Hungary|Budai Irgalmasrendi Korhaz, Budapest, Hungary|Szent Margit Rendelointezet, Budapest, Hungary|ClinDiab Kft., Budapest, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Strazsahegy Medicina Bt., Budapest, Hungary|Markhot Ferenc Korhaz, Eger, Hungary|Pharma4Trial, Gyongyos, Hungary|Selye Janos Korhaz-Rendelointezet, Komarom, Hungary|Kanizsai Dorottya Korhaz, Nagykanizsa, Hungary|SZTE I. sz. Belgyogyaszati Klinika, Szeged, Hungary|Clinfan Szolgaltato Kft., Szekszard, Hungary|Zala Megyei Szent Rafael Korhaz, Zalaegerszeg, Hungary|Care Hospital, Hyderabad, Andhra Pradesh, India|Sir Ganga Ram Hospital, New Delhi, Delhi, India|Gujarat Endocrine Center, Ahmedabad, Gujarat, India|Zydus Hospitals, Ahmedabad, Gujarat, India|CIMS Hospital Private Limited, Ahmedabad, Gujarat, India|Medanta-The Medicity, Gurgaon, Haryana, India|Topiwala National Medical College & BYL Nair Hospital, Mumbai, Maharashtra, India|Deenanth Mangeshkar Hospital and Research Centre, Pune, Maharashtra, India|Seth GS Medical College & KEM Hospital, Mumbai, Maharshtra, India|Dr Mohan's Diabetes Research Foundation, Chennai, Tamil Nadu, India|Apollo Gleneagles Hospitals, Kolkata, West Bengal, India|Batra Hospital & Medical Research Centre, New Delhi, India|Gobind Ballabh Pant Hospital, New Delhi, India|All India Institue of Medical Sciences (AIIMS), New Delhi, India|Sheba Medical Center, Ramat Gan, HaMerkaz, Israel|Haemek Medical Center- Dermatology, Afula, Israel|Barzilai Medical Center, Ashkelon, Israel|Clalit Health Services, Atlit, Atlit, Israel|Soroka Medical Center, Beer Sheva, Israel|Clinical Research Unit Hillel Yaffe M.C, Hadera, Israel|Bnai Zion Medical Center, Haifa, Israel|Rambam Medical Center, Haifa, Israel|Linn Medical Center, Haifa, Israel|Wolfson Medical Center, Holon, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Center, Jerusalem, Israel|Hadassah Medical Center, Jerusalem, Israel|Hadassah Medical Center, Jerusalem, Israel|Clalit Health Services -Diabetes and Endocrinology Clinic Jerusalem, Jerusalem, Israel|Meir Medical Center, Kfar Saba, Israel|Galilee Medical Center, Nahariya, Israel|Holy Family Hospital, Nazareth, Israel|Internal Medicine D, Ha'Sharon Hospital, Petach Tikwa, Israel|Rabin Medical Center, Petah Tiqva, Israel|Sheba Medical Center, Ramat Gan, Israel|Institute of Diabetes and Endocrinology Kaplan Medical Center, Rehovot, Israel|ZIV Medical Center, Safed, Israel|Sakhnin Community Clinic, Clalit Health Services, Sakhnin, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv Jaffa, Israel|Azienda ospedaliero-universitaria Mater Domini, Germaneto, Catanzaro, Italy|Centro Cardiologico Monzino, IRCCS, Milano, MI, Italy|Ospedale San Giovanni di Dio, Olbia, Olbia-Tempio, Italy|Policlinico di Tor Vergata, Roma, Rome, Italy|Ospedale Maggiore, Chieri, Turin, Italy|Azienda Ospedaliera Policlinico Consorziale, Bari, Italy|Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy|Policlinico S. Orsola Malpighi - Universita di Bologna, Bologna, Italy|Ospedale Garibaldi-Nesima, Catania, Italy|Fondazione Universitaria degli Studi G D'Annunzio, Chieti, Italy|Azienda Ospedaliera Universitaria - Careggi, Firenze, Italy|Gastroenterology and Endoscopy Unit IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milano, Italy|A.O.U. Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy|AOUP Paolo Giaccone, Palermo, Italy|Azienda Ospedaliera Di Parma, Parma, Italy|Fondazione Salvatore Maugeri, Pavia, Italy|Azienda Ospedlaliero-Univeristaria Pisana, Stabilimento Ospedaliero di Cisanello, Pisa, Italy|Policlinico Univ. Agostino Gemelli, Roma, Italy|Ospedale San Giovanni Calibita Fatebenefratelli, Roma, Italy|Ospedale Civile Maggiore Borgo Trento, Verona, Italy|Sakurabashi Watanabe Hospital, Kita-ku, Osaka, Japan|Takatsuki Red Cross Hospital, Takatsuki, Osaka, Japan|Tokyo Clinical Trial Centre Fukuwa Clinic, Chuo-ku, Tokyo, Japan|Tokyo-Eki Center-building Clinic, Chuo-ku, Tokyo, Japan|The Institute for Adult Diseases, Asahi Life Foundation, Chuou-ku, Tokyo, Japan|Sato Naika Clinic, Ota-ku, Tokyo, Japan|Uji-Tokushukai Medical Center, Makishima-cho, Uji-shi, Japan|Jinnouchi Hospital, Kumamoto, Japan|AMC nishi-umeda clinic, Osaka, Japan|Yonse University Wonju Severance Christian Hospital, Gangwon-do, Kang Won-do, Korea, Republic of|Asan Medical Center, Seoul, Korea, Korea, Republic of|Seoul St. Mary's Hospital, Seoul, Korea, Korea, Republic of|Ulsan University Hospital, Ulsan, Korea, Korea, Republic of|Keimyung University Dongsan Hospital, Daegu, Korea, Republic of|Korea University Anam Hospital, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Severance Hospital Yonsei University Health System, Seoul, Korea, Republic of|Kyunghee University Hospital at Gangdong, Seoul, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of|Hospital Cardiologica Aguascalientes, Aguascalientes, AGS, Mexico|CINCAME, Tijuana, Baja California, Mexico|Centro Especializado en Diabetes Obesidad y Enfermedades, Mexico, D.f., Mexico|Diseno y Planeacion en Investigacion Medica S.C., Guadalajara, Jalisco, Mexico|Unidad de Investigacion Clinica, Guadalajara, Jalisco, Mexico|Centro de Investigación Médica Integral S.C., Guadalajara, Jalisco, Mexico|Universidad de Guadalajara, Guadalajara, Jalisco, Mexico|Instituto Jalisciense de Investigacion en Diabetes y Obesida, Guadalajara, Jalisco, Mexico|Unidad de patologia Clinica, Guadalajara, Jalisco, Mexico|Salud Cardiovascular, Guadalajara, Jalisco, Mexico|Centro de Inv. Medica de Occidente, SC, Zapopan, Jalisco, Mexico|Inst. de Diabetes, Obesidad y Nutricion S.C, Cuernavaca, Morelos, Mexico|Hospital Universitario de Monterrey, Monterrey, Nuevo Leon, Mexico|Cardiolink Clin Trials S.C., Monterrey, Nuevo León, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico|Unidad Medica para la Salud Integral (UMSI), Monterrey, Nuevo León, Mexico|Centro Para el Desarrollo de la Medicina y de Asistencia Med, Culiacán, Sinaloa, Mexico|Centro de Estudios de Investigacion Metabolicos y Cardiovasc, Madero, Tamaulipas, Mexico|Consultorio de Medicina especializada del Sector Privado, Xalapa, Veracruz, Mexico|Medical Care and Research, S.A. de C.V., Merida, Yucatan, Mexico|Centro de Investigacion Medica Aguascalientes, Aguascalientes, Mexico|Investigacion en Salud y Metabolismo S.C, Chihuahua, Mexico|Lahoja Asociación para la Investigación y Farmacovigilancia S.C., Durango, Mexico|Oaxaca Site Management Organization SC, Oaxaca, Mexico|Centro De Estudios Clinicos De Queretaro S.C., Querétaro, Mexico|Rijnstate Arnhem, Arnhem, Gelderland, Netherlands|Canisius-Wilhelmina Ziekenhuis, Nijmegen, Gelderland, Netherlands|Jeroen Bosch Ziekenhuis 's-Hertogenbosch - Cardiologie, 's-Hertogenbosch, North Brabant, Netherlands|Amsterdam VUmc, Amsterdam, North Holland, Netherlands|Emotional Brain B.V., Almere, Netherlands|Ziekenhuis Amstelland, Amstelveen, Netherlands|Amsterdam AMC - Research Vasculaire Geneeskunde, Amsterdam, Netherlands|Reinier de Graaf Delft, Delft, Netherlands|Het Van Weel-Bethesda Ziekenhuis, Dirksland, Netherlands|Slingeland Ziekenhuis, Doetinchem, Netherlands|Ziekenhuis Gelderse Vallei, Ede, Netherlands|Maxima Medisch Centrum, locatie Eindhoven, Eindhoven, Netherlands|Spaarne Gasthuis, Haarlem Zuid, Haarlem, Netherlands|Röpcke-Zweers Ziekenhuis Hardenberg, Hardenberg, Netherlands|Ziekenhuis Bethesda, Hoogeveen, Netherlands|Universitair Medisch Centrum St Radboud Nijmegen, Nijmegen, Netherlands|Franciscus Gasthuis Rotterdam - Cardiologie, Rotterdam, Netherlands|Diakonessenhuis Utrecht - Cardiologie, Utrecht, Netherlands|UMC Utrecht, Dept. of Internal Medicine, MDL, Utrecht, Netherlands|Centrum Medyczne AMED, Warszawa, Mazowieckie, Poland|ETG Warszawa, Warszawa, Mazowieckie, Poland|Centrum Badan Klinicznych, PI House, Gdansk, Pomorskie, Poland|Poradnia Diabetologiczna SN ZOZ Lege Artis, Bialystok, Poland|NS ZOZ Osrodek Diabetologiczny "" Popula"", Bialystok, Poland|NZOZ Salvia s.c., Katowice, Poland|NZOZ Diab-Endo-Met, Krakow, Poland|Centrum Terapii Wspolczesnej J.M. Jasnorzewska S.K.A., Lodz, Poland|NZOZ CenterMed Lublin, Lublin, Poland|Gabinety Terpa, Lublin, Poland|NZOZ Przychodnia Specjalistyczna MEDICA, Lublin, Poland|Centrum Medyczne OMEDICA, Poznan, Poland|GAJA Poradnie Lekarskie, Poznan, Poland|Praktyka Lekarska, Poznan, Poland|NZOZ Przychodnia Specjalistyczna Henryk RudzkiAndrzej Wittek, Ruda Slaska, Poland|NZOZ Poradnia Diabetologiczno, Szczecin, Poland|Instytut Diabetologii Sp. z o.o, Warsaw, Poland|Poradnia Chorob Metabolicznych w Wierzchoslawicach, Wierzchoslawice, Poland|Regionalna Poradnia Diabetologiczna, Wroclaw, Poland|Woj. Zesp. Spec. Opieki Zdrowotnej, Wroclaw, Poland|Advanced Clinical Research, LLC, Bayamon, Puerto Rico|Manati Center for Clinical Research Inc, Manati, Puerto Rico|Research and Cardiovascular Corp., Ponce, Puerto Rico|GCM Medical Group PSC, San Juan, Puerto Rico|San Juan Hospital Research Unit, San Juan, Puerto Rico|Diana Barbonta SRL, Alba Iulia, Alba, Romania|SC Endodigest SRL, Oradea, Bihor, Romania|S. C. Grandmed S.R.L., Str., Oradea, Bihor, Romania|SC Gama Diamed SRL, Mangalia, Constanta, Romania|Top Diabet SRL, Craiova, Dolj, Romania|SC MiniMed SRL, Bacau, Jud. Bacau, Romania|SC Diamed Obesity SRL, Galati, Judetul Galati, Romania|CMI DNBM Dr. Pop Lavinia, Baia Mare, Maramures, Romania|Cosamext SRL, Targu Mures, Mures, Romania|SC Diabmed Dr Popescu Alexandrina SRL, Ploiesti, Prahova, Romania|SC Dianutrilife Medica SRL, Ploiesti, Prahova, Romania|Institutul National de Diabet Nutritie si Boli Metabolice, Bucharest, Sector 2, Romania|Centrul Medical Dr. Negrisanu, Timisoara, Timis, Romania|SC CMI Dr. Pletea Noemi SRL, Bacau, Romania|Centrul Medical de Diagnostic si Tratament Ambulatoriu Neomed SRL, Brasov, Romania|Cabinetul Medical Nicodiab SRL, Bucharest, Romania|Easydiet SRL, Bucuresti, Romania|SC Nutrilife SRL, Bucuresti, Romania|SC Olimpia Med SRL, Iasi, Romania|Consultmed SRL, Iasi, Romania|Arkhangelsk Regional Clinical Hospital, Arkhangelsk, Russian Federation|Arkhangelsk the first city clinical hospital, Arkhangelsk, Russian Federation|FSBI ""National Medical Research Center for Preventive Medicine"" of MOH of Russian Fed, Moscow, Russian Federation|FSBI Endocrinological Research Center of the MOH of the ROF, Moscow, Russian Federation|First Moscow State Medical University, Moscow, Russian Federation|FSBI ""National Medical Research Center of Cardiology"" of MOH of Russian Federation, Moscow, Russian Federation|FSBI ""National Medical Research Center of Cardiology"" of MOH of Russian Federation, Moscow, Russian Federation|Moscow State University of Medicine and Dentistry n.a. Evdokimov, Moscow, Russian Federation|Moscow State University of Medicine and Dentistry n.a. Evdokimov, Moscow, Russian Federation|First Moscow State Medical University n.a. Sechenov, Moscow, Russian Federation|Pirogov Russian National Research Medical University, Moscow, Russian Federation|M. F. Vladimirskiy Moscow Regional Research Clinical Institute, Moscow, Russian Federation|Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|Ryazan Regional Clinincal Cardiology Dispensary, Ryazan, Russian Federation|Ryazan Regional Clinincal Cardiology Dispensary, Ryazan, Russian Federation|Russian Medical Military Academy n.a. S.M. Kirov, Saint Petersburg, Russian Federation|City Hospital of Saint Martyr Elizabeth, Saint Petersburg, Russian Federation|ASTARTA Research Site, Saint Petersburg, Russian Federation|SPb SBIH ""City Mariinskaya Hospital"", Saint-Petersburg, Russian Federation|Regional Clinical Hospital, Saratov, Russian Federation|Syktyvkar Consulting Diagnostic Center, Syktyvkar, Russian Federation|Siberian State Medical University of Roszdrav, Tomsk, Russian Federation|OGUZ Tomsk Regional Clinical Hospital, Tomsk, Russian Federation|Research & Practice Ltd, Yaroslavl, Russian Federation|MUZ Clinical Hospital #2, Yaroslavl, Russian Federation|Diacrin s.r.o., Bratislava, Slovakia|IN-DIA, s.r.o., Lucenec, Slovakia|Sin Azucar, Malacky, Slovakia|FUNKYSTUFF s.r.o., Nove Zamky, Slovakia|DIABETOL s.r.o., Presov, Slovakia|DIA-MED CENTRUM s.r.o., Puchov, Slovakia|DIAB, s.r.o.,Diabetologicka ambulancia, Roznava, Slovakia|Tatratrial s.r.o., Roznava, Slovakia|MEDI-DIA s.r.o., Sabinov, Slovakia|Diabetes Centrum s.r.o, Trencin, Slovakia|Hospital Infanta Luisa, Sevilla, Andalucía, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Virgen Del Camino, Sanlucar de Barrameda, Cadiz, Spain|Hospital Virgen de las Montanas, Villamartin, Cadiz, Spain|Hospital Clinico Universitario de Valladolid, Valladolid, Castilla Y Leon, Spain|Hospital Naval de Ferrol, Ferrol, La Coruna, Spain|Hospital Clinico Universitario de Santiago, Santiago de Compostela, La Coruna, Spain|Hospital Universitario Principe de Asturias, Alcala de Henares, Madrid, Spain|Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain|Hospital de la Ribera, Alcira, Valencia, Spain|Centro Periférico de Especialidades Bola Azul, Almeria, Spain|Virgen de Las Nieves, Granada, Spain|Complexo Hospitalario Universitario A Coruña, CHUAC, La Coruña, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Centro Especialidades San Jose Obrero (Barbarela), Malaga, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Clinica Nuevas Tecnologias en Diabetes y Endocrinologia, Seville, Spain|Hospital General Universitario de Valencia, Valencia, Spain|CEIM Hospital Universitario y Politecnico la Fe, Valencia, Spain|Sahlgrenska Universitetssjukhuset, Göteborg, Gothenburg, Sweden|ProbarE i Skåne, Lund, Skåne, Sweden|Dalecarlia Clinical Research Center, Rättvik, Sweden|Citydiabetes,Serafen, Stockholm, Sweden|AKP - Avdelningen för Kliniska Prövningar, Örebro, Sweden|Östersund Sjukhus, Östersund, Sweden|Chang Gung Memorial Hospital - Linkou, Guei Shan Township, Taoyuan County, Taiwan|Changhua Christian Hospital, Changhua, Taiwan|Hsinchu Mackay Memorial Hospital, Hsinchu City, Taiwan|Buddhist Tzu-Chi General Hospital, Hualien, Taiwan|Chang Gung Memorial Hospital - Kaohsiung, Kaohsiung, Taiwan|Taichung Veterans General Hospital, Taichung, Taiwan|Chi-Mei Medical Center, Tainan City, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Ankara University Medicine Hospital, Mamak, Ankara, Turkey|Mersin University Medical Faculty, Yenişehir, Mersin, Turkey|Baskent Universitesi Adana, Adana, Turkey|Akdeniz University Medical Faculty, Antalya, Turkey|Aydin Adnan Menderes Universitesi, Aydin, Turkey|Dr. Sadi Konuk Egitim ve Arastirma Hastanesi, Bakırköy/İstanbul, Turkey|Pamukkale University, Denizli, Turkey|Dicle University Faculty of Medicine, Diyarbakir, Turkey|Osmangazi University, Eskisehir, Turkey|Gaziantep University Medical Faculty, Gaziantep, Turkey|Koç Üniversitesi Hastanesi, Istanbul, Turkey|Acıbadem Atakent Hastanesi, Istanbul, Turkey|Istanbul Medeniyet University Medical Faculty, Istanbul, Turkey|Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey|Ege University Faculty of Medicine, Izmir, Turkey|Dokuz Eylul University Hospital, Izmir, Turkey|Kocaeli University Medical Faculty Hospital, Izmit, Turkey|Erciyes University Hospital, Kayseri, Turkey|Inonu University Medical Faculty, Malatya, Turkey|Ataturk University Faculty of Medicine, Yakutiye/ERZURUM, Turkey|Regional Public Institution ""Chernivtsi Regional Endocrinology Center"", Chernivtsi, Ukraine|Ukrainian State Research Institute of medical and social problems of disability, Dnipro, Ukraine|Dnipro City Clinical Hospital #9, Dnipro, Ukraine|CHI Prof.O.O.Shalimov Kharkiv City Clinical Hospital #2, Kharkiv, Ukraine|GI L.T. Malaya TI Namsu, Kharkiv, Ukraine|LEC Communal Inst Hc Kharkiv City Clinical Hosp #8, Kharkiv, Ukraine|International Institute of Clinical Trials LLC, Kyiv, Ukraine|Medical Center of LLC Medbud-Clinic, Kyiv, Ukraine|Administration of Medical Service and Rehabilitation of ""ARTEM"" State Holding Company, Kyiv, Ukraine|Medical Centre CONSILIUM MEDICAL, Kyiv, Ukraine|V.P. Komisarenko Institute of Endocrinology and Metabolism of NAMS of Ukraine, Kyiv, Ukraine|V.P. Komisarenko Institute of Endocrinology and Metabolism of NAMS of Ukraine, Kyiv, Ukraine|Polyclinic of Communal 4th city clinical hospital, Lviv, Ukraine|Lviv Regional State Clinical Treatment and Diagnostic Endocrinology Center, Lviv, Ukraine|Communal Enterprise ""Odesa Regional Clinical Hospital"", Odesa, Ukraine|Public Institution City, Odessa, Ukraine|Communal Institution ""Poltava Reg.Cl.H. n.a.M.V.Sklifosovskogo"", Poltava, Ukraine|Central City Clinical Hospital No. 1, Poltava, Ukraine|KZ SOR ""Sum. OKL"" [v end], SDMU, k vn med z kursom proped, Sumy, Ukraine|Vinnytsia Regional Clinical Highly Specialized Endocrinology Center, Vinnytsia, Ukraine|Municipal Institution City Hospital #7, Zaporizhzhia, Ukraine|Southmead Hospital, Westbury On Trym, Bristol, United Kingdom|The Staploe Medical Centre, Soham, Ely, Cambridgeshire, United Kingdom|Royal Cornwall Hospital, Truro, Cornwall, United Kingdom|Knowle House Surgery, Plymouth, Devon, United Kingdom|The Royal Blackburn Hospital, Blackburn, Lanchashire, United Kingdom|Leicester General Hospital, Leicester, Leicestershire, United Kingdom|Wythenshawe Hospital, Wythenshawe, Manchester, United Kingdom|Queen's MedicaL Centre/University of Nottingham, Nottingham, Nottinghamshire, United Kingdom|Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom|Ninewells Hospital, Dundee, Scotland, United Kingdom|Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom|Ipswich Hospital, Ipswich, Suffolk, United Kingdom|Morriston Hospital, Swansea, Wales, United Kingdom|The Dudley Group NHS Foundation Trust, Dudley, West Midlands, United Kingdom|Hull Royal Infirmary - MAIN, Hull, Yorkshire, United Kingdom|Monklands Hospital, Airdrie, United Kingdom|University Hospital Aintree, Liverpool, United Kingdom","https://ClinicalTrials.gov/show/NCT04255433"
34,"NCT04445714","To Assess the Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Indian Type 2 Diabetes Mellitus.","Not yet recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: dapagliflozin and saxagliptin","June 24, 2020",,"https://ClinicalTrials.gov/show/NCT04445714"
35,"NCT04277780","Reducing Emergency Department Visits and Improving Glucose Control in Uncontrolled Type 2 Diabetes Using CGM Sensors at Hospital Discharge","Recruiting","No Results Available","Type 2 Diabetes Mellitus","Device: Continuous Glucose Monitoring Sensor|Other: Diabetes Management Instructions","February 20, 2020","Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04277780"
36,"NCT04218734","A Study to Evaluate the Efficacy and Safety of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With Type 2 Diabetes Mellitus","Not yet recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: DBPR108|Drug: metformin hydrochloride|Drug: placepo","January 6, 2020",,"https://ClinicalTrials.gov/show/NCT04218734"
37,"NCT04285983","Specified Drug-Use Survey of Trelagliptin Tablets ""Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease""","Recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: Trelagliptin","February 26, 2020","Takeda Selected Site, Tokyo, Japan","https://ClinicalTrials.gov/show/NCT04285983"
38,"NCT04283201","Type 2 Diabetes Mellitus Prevention Ukraine","Active, not recruiting","No Results Available","Evaluation of Lifestyle Modification for the Prevention of Type 2 Diabetes","Other: Lifestyle modification","February 25, 2020","V.P.Komisarenko Institute of Endocrinology and Metabolism, Kyiv, Ukraine","https://ClinicalTrials.gov/show/NCT04283201"
39,"NCT04232774","Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities","Recruiting","No Results Available","Type 2 Diabetes Mellitus With Circulatory Complciation","Device: The Neurotronic arterial ablation catheter","January 18, 2020","Sanatorio Italiano - Centro de Intervenciones Endovasculares, Asunción, Paraguay","https://ClinicalTrials.gov/show/NCT04232774"
40,"NCT04371497","Switch From U-100 Insulin Analog to U-500 Regular Insulin in Pumps for Type 2 Diabetes","Completed","No Results Available","Glucose Control in Patients With Type 2 Diabetes Mellitus Treated by U-500 Insulin Administered by a Pump Device",,"May 1, 2020",,"https://ClinicalTrials.gov/show/NCT04371497"
41,"NCT04214600","Cognitive Behavioral Therapy for Adherence in Patients With Type 2 Diabetes","Active, not recruiting","No Results Available","Type 2 Diabetes|Depression","Behavioral: Cognitive Behavioral Therapy (CBT)","January 2, 2020","Al-Agouza Family Medicine Center (AFMC)., Agouza, Giza, Egypt","https://ClinicalTrials.gov/show/NCT04214600"
42,"NCT04228003","Pendulum D2D Glucose Control for Adults With Type 2 Diabetes","Not yet recruiting","No Results Available","Type2 Diabetes|Gastrointestinal Symptoms","Dietary Supplement: Pendulum Glucose Control formulation for T2D","January 14, 2020","USC Westside Center for Diabetes, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT04228003"
43,"NCT04261361","Cognitive Behavioural Therapy for Adherence and Sub-clinical Depression for Type 2 Diabetes","Recruiting","No Results Available","Type 2 Diabetes|Depression","Behavioral: CBT-AD intervention|Behavioral: Adherence counseling|Behavioral: Psycho-education package","February 7, 2020","Applied Social Sciences, Hong Kong Polytechnic University, Hong Kong, Hong Kong|Institute of Active Ageing, Kowloon, Hong Kong","https://ClinicalTrials.gov/show/NCT04261361"
44,"NCT04307797","Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 Diabetes","Not yet recruiting","No Results Available","Type2 Diabetes|Obesity","Drug: 0.9% Sodium-chloride|Drug: Exenatide (50ng/min for 30 minutes loading followed by 25ng/min maintenance) and glucagon 12.5ng/kg/min","March 13, 2020",,"https://ClinicalTrials.gov/show/NCT04307797"
45,"NCT04417725","Burden of Chronic Kidney Disease (CKD), Type 2 Diabetes Mellitus (T2DM), and Comorbid T2DM/CKD in Alberta, Canada","Not yet recruiting","No Results Available","Chronic Kidney Diseases|Type 2 Diabetes",,"June 5, 2020",,"https://ClinicalTrials.gov/show/NCT04417725"
46,"NCT04449120","HOME COOKING: Health Empowerment Strategy in People With Type II Diabetes Mellitus","Recruiting","No Results Available","Type 2 Diabetes Mellitus","Behavioral: Mediterranean diet-based culinary intervention|Behavioral: Mediterranean diet-based nutritional education intervention","June 26, 2020","Basque Culinary Center, Donostia-San Sebastian, Guipuzcoa, Spain","https://ClinicalTrials.gov/show/NCT04449120"
47,"NCT04218305","Fetuin-A as a Marker in Obesity and Type 2 Diabetes Mellitus","Completed","No Results Available","Diabete Type 2","Diagnostic Test: Serum Level Of Fetuin A","January 6, 2020",,"https://ClinicalTrials.gov/show/NCT04218305"
48,"NCT04305587","Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus","Recruiting","No Results Available","Diabetes Mellitus Type 2","Drug: PF-07081532|Other: Placebo|Drug: Clopidogrel","March 12, 2020","Anaheim Clinical Trials, LLC, Anaheim, California, United States|Qps-Mra, Llc, South Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT04305587"
49,"NCT04314427","Early Glycaemic Control in Type 2 Diabetes Patients After Bariatric Surgery; ECODABS","Completed","No Results Available","Diabetes Mellitus Type 2 in Obese","Procedure: Roux-en-Y gastric bypass|Procedure: Sleeve gastrectomy","March 19, 2020","Antwerp University Hospital, Antwerp, Edegem, Belgium|Universitair Ziekenhuis, Brussel, Jette, Belgium|Gent University Hospital, Gent, Belgium|Hospital Clinico San Carlos, Madrid, Spain|Sahlgrenska University Hospital, Gothenburg, Sweden|Sahlgrenska University Hospital, Gothenburg, Sweden|Karolinska Institutet, Stockholm, Sweden|South kensington campus, London, United Kingdom","https://ClinicalTrials.gov/show/NCT04314427"
50,"NCT04222738","The Cardiovascular Effects of Ginger (Zingiber Officinale) in Patients With Type II Diabetes Mellitus","Completed","No Results Available","Cardiovascular Benefits of Zingiber Officinale Roscoe in Patients With Type 2 Diabetes Mellitus Before and After 6 Weeks of add-on Therapy","Dietary Supplement: GINOFF1","January 10, 2020","Yaounde Central Hospital, NAtional Obesity Center, Yaounde, Cameroon","https://ClinicalTrials.gov/show/NCT04222738"
51,"NCT04268212","An Alternative Approach to Improve Hyperglycemia Among Type 2 Diabetes Patients","Completed","No Results Available","Type2 Diabetes","Dietary Supplement: Bitter melon juice (100 ml)|Behavioral: Exercise","February 13, 2020",,"https://ClinicalTrials.gov/show/NCT04268212"
52,"NCT04330911","The Effects of Aerobic Exercises on Exercise Capacity in Type-2 Diabetes Mellitus","Completed","No Results Available","Type-2 Diabetes","Procedure: Aerobic Exercise","April 2, 2020","Marmara University, Istanbul, Turkey","https://ClinicalTrials.gov/show/NCT04330911"
53,"NCT04405895","Effect of Meal Timing in T2D on Hepatocytes SRIT1 and Clock Genes","Not yet recruiting","No Results Available","Type 2 Diabetes|Obesity","Other: Breakfast Diet|Other: Allday Diet","May 28, 2020","Wolfson Medical Center, Holon, Please Select, Israel","https://ClinicalTrials.gov/show/NCT04405895"
54,"NCT04271189","Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs","Not yet recruiting","No Results Available","Newly Diagnosed Type 2 Diabetes","Drug: Metformin-Sitagliptin-Empaglifozin-Pioglitazone|Drug: Standard of care","February 17, 2020","Azienda Ospedaliero Universitaria, Parma, Italy","https://ClinicalTrials.gov/show/NCT04271189"
55,"NCT04299763","Oat Beta-glucan as a Supplement in Chilean Type 2 Diabetics","Completed","No Results Available","Type2 Diabetes","Dietary Supplement: Oat Beta-glucan as a Supplement in Type 2 Diabetics","March 9, 2020","Centro de Estudios en Alimentación y Nutrición, Talca, Maule, Chile","https://ClinicalTrials.gov/show/NCT04299763"
56,"NCT04390295","Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes","Recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: Placebo|Drug: SHR3824|Drug: metformin","May 15, 2020","Third Affiliated Hospital of Sun Yat - sen University, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT04390295"
57,"NCT04392570","The Effect of Fasting on Serum Osmolarity in Diabetic Patients","Completed","No Results Available","Type2 Diabetes","Diagnostic Test: Fasting","May 19, 2020","IMU Goztepe Education and Research Hospital, Istanbul, Kadikoy, Turkey","https://ClinicalTrials.gov/show/NCT04392570"
58,"NCT04424706","The Effect and Mechanism of MMP-9 in Inducing Atherosclerosis","Not yet recruiting","No Results Available","Type 2 Diabetes","Diagnostic Test: diagnosed as type 2 diabetes without atherosclerosis|Diagnostic Test: diagnosed as type 2 diabetes with atherosclerosis|Diagnostic Test: people without type 2 diabetes or atherosclerosis","June 11, 2020","Nanjing First Hospital, Nanjing, Jiangsu, China","https://ClinicalTrials.gov/show/NCT04424706"
59,"NCT04282395","Resilience-Based Diabetes Self-Management Education (RB-DSME) for African Americans","Recruiting","No Results Available","Type 2 Diabetes","Behavioral: Resilience-Based Diabetes Self-Management Education|Behavioral: Standard Diabetes Self-Management Education","February 24, 2020","University of Texas at Austin, Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT04282395"
60,"NCT04234581","The Effect of Lysulin on Glycemic Control and Advanced Glycation","Recruiting","No Results Available","Type 2 Diabetes","Dietary Supplement: Lysulin","January 21, 2020","Phoenix VA Healthcare System, Phoenix, Arizona, United States|Phoenix VA Medical Center, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT04234581"
61,"NCT04383197","Exercise and GLP-1 RA on Insulin Secretion","Recruiting","No Results Available","Type 2 Diabetes","Behavioral: Endurance exercise training|Drug: Semaglutide","May 12, 2020","Xlab, Center for Healthy Aging, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT04383197"
62,"NCT04274660","Evaluation of Diabetes and WELLbeing Programme","Recruiting","No Results Available","Type 2 Diabetes|Type 2 Diabetes Treated With Insulin","Behavioral: DWELL (Diabetes and WELLbeing) Programme","February 18, 2020","Arteveldehogeschool, Ghent, Belgium|Centre Hosptalier Douai, Douai, France|Kinetic Analysis, Breda, 's-Hertogenbosch, Netherlands|Medway Community Healthcare, Gillingham, Kent, United Kingdom|Blackthorn Trust, Maidstone, Kent, United Kingdom","https://ClinicalTrials.gov/show/NCT04274660"
63,"NCT04311853","Evidence-Based Nutrition Practice Guidelines of Toolkit and Preliminary Outcomes","Completed","No Results Available","Type 2 Diabetes Mellitus",,"March 17, 2020",,"https://ClinicalTrials.gov/show/NCT04311853"
64,"NCT04254029","The Cardiovascular and Renal Effects of Moringa Oleifera Extracts and Stevia Rebaudiana Bertoni in Patients With Type II Diabetes Mellitus","Completed","No Results Available","Benefits of a Capsules of Moringa Oleifera and Stevia Rebaudiana Bertoni in Patients With Type 2 Diabetes Mellitus Before and After 45 Days of add-on Therapy","Dietary Supplement: MOROLSTEVER1","February 5, 2020","Yaounde Central Hospital, NAtional Obesity Center, Yaounde, Cameroon","https://ClinicalTrials.gov/show/NCT04254029"
65,"NCT04383314","Targeting Hyaluronan Accumulation Through Exercise in T2DM","Not yet recruiting","No Results Available","Type 2 Diabetes Mellitus","Behavioral: 10-week exercise program on HA accumulation","May 12, 2020",,"https://ClinicalTrials.gov/show/NCT04383314"
66,"NCT04298515","Nesfatin-1 Level in Patients With Type 2 Diabetes, Insulin Resistance and Obesity","Recruiting","No Results Available","Type 2 Diabetes|Insulin Resistance|Obesity|Nesfatin-1","Diagnostic Test: Nesfatin-1","March 6, 2020","Haydarpaşa Numune Education and Research Hospital, İstanbul, Turkey","https://ClinicalTrials.gov/show/NCT04298515"
67,"NCT04303819","The Effect of Exenatide on Fasting Bile Acids","Completed","No Results Available","Type 2 Diabetes Mellitus in Obese","Drug: Exenatide treatment","March 11, 2020","Beijing Chao-yang hospital, Beijing, China","https://ClinicalTrials.gov/show/NCT04303819"
68,"NCT04440319","Diabetes Nutrition Education With Glycemic Control","Enrolling by invitation","No Results Available","Type2 Diabetes Mellitus","Behavioral: Intervention group","June 19, 2020","Ice Yolanda Puri, Padang, WEST Sumatera, Indonesia","https://ClinicalTrials.gov/show/NCT04440319"
69,"NCT04341935","Effects of DPP4 Inhibition on COVID-19","Not yet recruiting","No Results Available","Coronavirus Infection|Type 2 Diabetes","Drug: Linagliptin|Drug: Insulin regimen","April 10, 2020","University of Miami, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT04341935"
70,"NCT04390711","Association of Carbamylated HDL and CAD in T2DM Patients","Completed","No Results Available","Type 2 Diabetes Mellitus With Circulatory Complciation","Other: High density lipoprotein isolation, detection and in-vitro study.","May 15, 2020","Rui Jin Hospital, Shanghai, China","https://ClinicalTrials.gov/show/NCT04390711"
71,"NCT04283318","Prolonged Fasting on Glucose Metabolism and Hormonal Regulation in Healthy, Obese and Subjects With Type 2 Diabetes","Recruiting","No Results Available","Healthy|Obesity|Type 2 Diabetes Mellitus|Type 1 Diabetes","Behavioral: 12h fasting|Behavioral: 36h fasting","February 25, 2020","Medical University of Graz, Graz, Austria","https://ClinicalTrials.gov/show/NCT04283318"
72,"NCT04243174","The Use of Short SMS Messaging With Type 2 Diabetes (T2DM)","Completed","No Results Available","Type 2 Diabetes|Physical Exercise","Behavioral: SMS Messaging","January 28, 2020","King Fahd Medical City, Riyadh, Saudi Arabia","https://ClinicalTrials.gov/show/NCT04243174"
73,"NCT04432337","Role of Type 2 Diabetes in Potentiating the Inflammatory Response Post Extracorporeal Circulation After Cardiac Surgery","Not yet recruiting","No Results Available","Inflammatory Response|Extracorporeal Circulation; Complications|Cardiac Surgery|Type 2 Diabetes","Procedure: The role of the activation of the NLRP3 inflammasome after cardiac surgery","June 16, 2020","CHU de Martinique, Fort-de-France, Martinique","https://ClinicalTrials.gov/show/NCT04432337"
74,"NCT04316429","The Impact of Consumption of Eggs in the Context of Plant-Based Diets on Endothelial Function, Diet Quality, and Cardio-Metabolic Risk Factors in Adults at Risk for Type 2 Diabetes","Recruiting","No Results Available","Type 2 Diabetes|Cardiovascular Diseases","Other: Egg included vegan phase|Other: Vegan Phase","March 20, 2020","Yale-Griffin Prevention Research Center, Derby, Connecticut, United States","https://ClinicalTrials.gov/show/NCT04316429"
75,"NCT04289818","The Effectiveness of ""CARE Coaching Model"" as an Effort to Empower Type 2 Diabetes Mellitus Patients","Active, not recruiting","No Results Available","Diabetes Type 2","Other: Health Coaching","February 28, 2020","Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, DKI Jakarta, Indonesia","https://ClinicalTrials.gov/show/NCT04289818"
76,"NCT04226846","Feasibility Trial of the Bios Device for Continuous Glucose Monitoring","Recruiting","No Results Available","Type 1 Diabetes|Type 2 Diabetes",,"January 13, 2020","Diablo Clinical Research, Inc, Walnut Creek, California, United States","https://ClinicalTrials.gov/show/NCT04226846"
77,"NCT04272359","Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus","Recruiting","No Results Available","T2DM (Type 2 Diabetes Mellitus)|Diet, Healthy|Renal Function Disorder|Albuminuria","Drug: Sulfa-zero: possible benefits of the treatment of new generation hypoglycaemic drugs compared to sulphonylureas","February 17, 2020","ASST FBF-Sacco P.O. Sacco/Fatebenefratelli e Oftalmico, Milano, Italy","https://ClinicalTrials.gov/show/NCT04272359"
78,"NCT04365400","TRIgyceride And Glucose Control With Epeleuton in Metabolic Syndrome Patients","Not yet recruiting","No Results Available","Hypertriglyceridemia|Type 2 Diabetes","Drug: DS102|Drug: Placebo","April 28, 2020",,"https://ClinicalTrials.gov/show/NCT04365400"
79,"NCT04303364","CARdiomyopathy in Type 2 DIAbetes Mellitus","Not yet recruiting","No Results Available","Cardiomyopathy, Diabetic",,"March 11, 2020","Cardiology Outpatient Department at Hôpital Henri Mondor., Créteil, France|Hopital Louis Pradel, Lyon, France|department of diabetology and nutrition, APHM, Marseille, France|Diabetology departement, Lariboisière Hospital, Paris, France|Diabetology department, Cochin Institute, Paris, France|Pitié-Salpêtrière hospital, Paris, France|University Hospital Aachen, Aachen, Germany|University Hospital Heidelberg, Heidelberg, Germany|Amsterdam UMC, location VUmc, Amsterdam, Netherlands|University Medical Center Groningen (UMCG), Cardiology/Cardio Research, Groningen, Netherlands|Academisch ziekenhuis Maastricht, Cardiology, Maastricht, Netherlands|UMC Utrecht, Cardiology (DHL), Utrecht, Netherlands|Hospital Vall Hebrón, Barcelona, Spain|Hospital Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|University of Dundee, Div of Molecular&Clinical Medicine, Dundee, United Kingdom","https://ClinicalTrials.gov/show/NCT04303364"
80,"NCT04349696","Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)","Completed","No Results Available","Type 2 Diabetes Mellitus|Liver Dysfunction","Drug: Mitiglinide","April 16, 2020","Chiayi Chang Gung Memorial Hospital, Chiayi City, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT04349696"
81,"NCT04222686","Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients","Completed","No Results Available","Type 2 Diabetes Mellitus","Drug: Perindopril Arginine|Drug: Losartan Potassium","January 10, 2020","Yaounde Central Hospital, NAtional Obesity Center, Yaounde, Cameroon","https://ClinicalTrials.gov/show/NCT04222686"
82,"NCT04227769","IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes","Recruiting","No Results Available","Diabetes Mellitus Type 2 in Obese|Inflammation|Metabolic Disease|Glucose Metabolism Disorders (Including Diabetes Mellitus)","Drug: Anakinra Prefilled Syringe","January 14, 2020","University Hospital Basel, Basel, Basel BS, Switzerland","https://ClinicalTrials.gov/show/NCT04227769"
83,"NCT04233229","Evaluation of a Closed-loop Insulin Delivery System at Home With Tailored Home Care Services in Poorly Controlled DT2","Recruiting","No Results Available","Diabete Type 2","Device: t:slim X2 with Control-IQ|Other: home healthcare services|Other: usual care for daily insulin treatment","January 18, 2020","CHU Caen, Caen, France","https://ClinicalTrials.gov/show/NCT04233229"
84,"NCT04227626","Inpatient Closed Loop Glucose Control With the Gen 2 GlucoSTAT","Not yet recruiting","No Results Available","Type 1 Diabetes|Type 2 Diabetes Treated With Insulin","Device: GlucoSTAT","January 13, 2020","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04227626"
85,"NCT04266054","Stories for Change: Digital Storytelling for Diabetes Self-Management Among Somali Adults","Recruiting","No Results Available","Type2 Diabetes","Behavioral: Digital Storytelling Intervention","February 12, 2020","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04266054"
86,"NCT04256486","Family Model Diabetes Self-Management Education in Faith Based Organizations","Not yet recruiting","No Results Available","Type 2 Diabetes","Behavioral: Family Model Diabetes Self-Management Education and Support","February 5, 2020",,"https://ClinicalTrials.gov/show/NCT04256486"
87,"NCT04347291","Mobile Phone Support for Adults and Support Persons to Live Well With Diabetes","Enrolling by invitation","No Results Available","Type 2 Diabetes","Behavioral: FAMS 2.0|Behavioral: Print Materials","April 15, 2020","Vanderbilt University Medical Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT04347291"
88,"NCT04254653","Diabetes Nutrition Education for American Indian and Alaska Native Communities","Recruiting","No Results Available","Type 2 Diabetes","Behavioral: American Indian and Alaska Native What Can I Eat?","February 5, 2020","Lakeport Tribal Health Consortium, Lakeport, California, United States|Indian Health Care Resource Center of Tulsa, Tulsa, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT04254653"
89,"NCT04226027","Dynamically Tailored Behavioral Interventions in Diabetes","Recruiting","No Results Available","Type 2 Diabetes","Behavioral: T2.coach","January 13, 2020","Clinical Directors Network, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04226027"
90,"NCT04348565","Diabetes Care Programme for Type 2 Diabetes Mellitus in Primary Care Setting","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Other: Diabetes Care Programme","April 16, 2020","Clinics of private general practitioners, Hong Kong, Hong Kong SAR, Hong Kong","https://ClinicalTrials.gov/show/NCT04348565"
91,"NCT04334213","A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150","Not yet recruiting","No Results Available","Type 2 Diabetes","Drug: CKD-501|Drug: D745, D150|Drug: CKD-501, D745, D150","April 6, 2020",,"https://ClinicalTrials.gov/show/NCT04334213"
92,"NCT04322032","Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389","Not yet recruiting","No Results Available","Type 2 Diabetes","Drug: Reference drug|Drug: Test drug","March 26, 2020","Chonbuk National University Hospital, Jeonju, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04322032"
93,"NCT04317703","Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.","Not yet recruiting","No Results Available","Type 2 Diabetes","Drug: Gemigliptin tartrate sesquihydrate and metformin|Drug: gemigliptin 50 mg and metformin hydrochloride 1000 mg prolonged release","March 23, 2020",,"https://ClinicalTrials.gov/show/NCT04317703"
94,"NCT04304430","Comparative Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors","Completed","No Results Available","Type 2 Diabetes","Drug: Dapagliflozin|Drug: DPP-4 inhibitor","March 11, 2020","University Hospital of Padova, Padova, Italy","https://ClinicalTrials.gov/show/NCT04304430"
95,"NCT04411277","Time in Range (TIR) and Time Below Range (TBR) in Insulin-Treated Elderly Patients With Type 2 Diabetes","Not yet recruiting","No Results Available","Continuous Glucose Monitoring","Device: Application of the FreeStyle Libre Flash Glucose CGM.|Diagnostic Test: InBody 270 multifrequency bioimpedance","June 2, 2020",,"https://ClinicalTrials.gov/show/NCT04411277"
96,"NCT04446026","A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen","Not yet recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: teneligliptin|Drug: Placebo","June 24, 2020","Yonsei Severance Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04446026"
97,"NCT04267601","Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM","Recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: Anagliptin","February 13, 2020","The Catholic University of Korea, Bucheon ST. Mary's hopsital, Bucheon, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04267601"
98,"NCT04246190","A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396","Not yet recruiting","No Results Available","Type2 Diabetes Mellitus","Drug: CKD-501 and D759|Drug: CKD-396","January 29, 2020","Yonsei University Severance Hospital, Soeul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04246190"
99,"NCT04223895","A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers","Not yet recruiting","No Results Available","Type2 Diabetes Mellitus","Drug: CKD-386 Formulation 1|Drug: CKD-386 Formulation 2|Drug: D012, D326 and D337","January 10, 2020",,"https://ClinicalTrials.gov/show/NCT04223895"
100,"NCT04221360","A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375","Not yet recruiting","No Results Available","Type2 Diabetes Mellitus","Drug: CKD-375|Drug: D390","January 9, 2020","Yonsei University Severance Hospital, Soeul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04221360"
101,"NCT04431687","A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)","Not yet recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: CKD 501|Drug: D759, D150|Drug: CKD-501, D759, D150","June 16, 2020",,"https://ClinicalTrials.gov/show/NCT04431687"
102,"NCT04431141","Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin","Not yet recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: Teneligliptin|Drug: Empagliflozin|Drug: Teneligliptin and Empagliflozin","June 16, 2020","Clinical Pharmacology, Asan Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04431141"
103,"NCT04426708","A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers","Recruiting","No Results Available","Type 2 Diabetes Mellitus","Drug: HMS5552","June 11, 2020","West China Hospital of Sichuan University, Chengdu, Sichuan, China","https://ClinicalTrials.gov/show/NCT04426708"
104,"NCT04324424","A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers","Completed","No Results Available","Type 2 Diabetes Mellitus","Drug: HMS5552","March 27, 2020","West China Hospital of Sichuan University, Chengdu, Sichuan, China","https://ClinicalTrials.gov/show/NCT04324424"
105,"NCT04339530","Vitamin D and Type 2 Diabetes Risk in UK Adults","Recruiting","No Results Available","Overweight|Obesity","Other: Normal weight and overweight adults","April 9, 2020","School of Health sciences, Liverpool, United Kingdom","https://ClinicalTrials.gov/show/NCT04339530"
106,"NCT04298684","Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|Thyroid Nodule (Benign)","Drug: METFORMIN|Drug: Sitagliptin","March 6, 2020","CHU Bordeaux, Bordeaux, France|CHU Limoges, Limoges, France|University Hospital Center of Guadeloupe, Pointe-à-Pitre, Guadeloupe|CHU de la Réunion, Saint-Pierre, Réunion","https://ClinicalTrials.gov/show/NCT04298684"
107,"NCT04389775","To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants","Recruiting","No Results Available","Type 2 Diabetes Mellitus|NASH - Nonalcoholic Steatohepatitis","Drug: XW003|Drug: Volume-matching Placebo","May 15, 2020","Nucleus Network, Melbourne, Victoria, Australia","https://ClinicalTrials.gov/show/NCT04389775"
108,"NCT04318184","Effects of Exercise on Metabolic Parameters in Patients With Type 2 Diabetes Mellitus","Completed","No Results Available","Diabetes Mellitus, Type 2","Procedure: Aerobic exercise","March 23, 2020","Fatih Sultan Mehmet Eğitim ve Araştırma Hastanesi, Istanbul, Turkey","https://ClinicalTrials.gov/show/NCT04318184"
109,"NCT04232293","Screening of Liver Fibrosis in Patients With Type 2 Diabetes Mellitus","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|NAFLD|NASH","Diagnostic Test: Blood tests","January 18, 2020","CHU d'Angers, Angers, France|CHU de Nantes, Nantes, France","https://ClinicalTrials.gov/show/NCT04232293"
110,"NCT04433598","Effectiveness of Nutrition Education Intervention on Glycemic Control (HbA1c)","Completed","No Results Available","Type 2 Diabetes|Diet, Healthy|Health Knowledge, Attitudes, Practice","Behavioral: Nutrition Education Intervention","June 16, 2020","Al-Faiha Diabetes Endocrine and Metabolism Center (FDEMC), Basrah, Iraq","https://ClinicalTrials.gov/show/NCT04433598"
111,"NCT04216849","Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy","Recruiting","No Results Available","Type 2 Diabetes With Renal Manifestations","Biological: human umbilical cord mesenchymal stem cells|Other: saline","January 3, 2020","Shanghai East Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04216849"
112,"NCT04270656","Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 With Non-alcoholic Hepatic Steatosis","Not yet recruiting","No Results Available","Type 2 Diabetes (T2D)","Procedure: Insulin pump therapy|Procedure: Multi-injection treatment ( MDI ).","February 17, 2020","CHU, Angers, France|CHU, Caen, France|CHU, Dijon, France|CHU, La Rochette, France|Hospices Civils, Lyon, France|Nantes UH, Nantes, France|CHU, Poitiers, France|CHU, Toulouse, France","https://ClinicalTrials.gov/show/NCT04270656"
113,"NCT04386200","Web-based Approach in Nutrition and Diabetes","Active, not recruiting","No Results Available","Type 2 Diabetes Mellitus|Overweight and Obesity|Nutritional and Metabolic Diseases","Other: web-based thecnologies|Behavioral: traditional approach","May 13, 2020","Hospital ""SS Annunziata"", Chieti, Italy","https://ClinicalTrials.gov/show/NCT04386200"
114,"NCT04236206","Short Message Service for Type 2 Diabetes","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Behavioral: Mobile Phone Short Message Service","January 22, 2020","Family Health Centers, Alexandria, Egypt","https://ClinicalTrials.gov/show/NCT04236206"
115,"NCT04413357","Glycemic Response in Persons With Type 2 Diabetes","Enrolling by invitation","No Results Available","Diabetes Mellitus, Type 2","Other: Oral Nutrition Supplement","June 2, 2020","Orange County Research Center, Tustin, California, United States","https://ClinicalTrials.gov/show/NCT04413357"
116,"NCT04219800","Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Behavioral: Patient-centered counselling and written material|Behavioral: mHealth","January 7, 2020","Hertsöns Hälsocentral, Luleå, Norrbotten, Sweden","https://ClinicalTrials.gov/show/NCT04219800"
117,"NCT04295031","Metformin in Older Adults With Type 2 Diabetes (AMEMET)","Recruiting","No Results Available","Diabetes Mellitus, Type 2",,"March 4, 2020","AME - Associazione Medici Endocrinologi, Udine, Italy","https://ClinicalTrials.gov/show/NCT04295031"
118,"NCT04412798","Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Other: orange juice concentrate|Other: Sugar-sweetened orange-flavoured beverage|Other: Whole orange juice with skin removed","June 2, 2020","Hasselt University, Hasselt, Belgium","https://ClinicalTrials.gov/show/NCT04412798"
119,"NCT04374578","Effect of Dulaglutide on Improve Glycemic Variability With Type 2 Diabetes","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Dulaglutide 1.5Mg/0.5Ml Inj Pen","May 5, 2020",,"https://ClinicalTrials.gov/show/NCT04374578"
120,"NCT04303754","Diabetes-Specific Formula in Individuals With Type 2 Diabetes","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Other: Diabetes-Specific Formula|Other: Bread with Spread|Other: Mashed Potato","March 11, 2020","Hospital Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia","https://ClinicalTrials.gov/show/NCT04303754"
121,"NCT04426474","A Study of LY3502970 in Participants With Type 2 Diabetes","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: LY3502970|Drug: Placebo","June 11, 2020","Clinical Pharmacology of Miami, Hialeah, Florida, United States|Hassman Research Institute, Marlton, New Jersey, United States|Midwest Clinical Research Unit, Dayton, Ohio, United States|Endeavor Clinical Trials, San Antonio, Texas, United States|Profil Institut für Stoffwechselforschung, Neuss, Nordrhein-Westfalen, Germany|Profil Mainz GmbH & Co. KG, Mainz, Rheinland-Pfalz, Germany","https://ClinicalTrials.gov/show/NCT04426474"
122,"NCT04216654","Role of Helicobacter Pylori in Microalbuminuria","Completed","No Results Available","Microalbuminuria Due to Type 2 Diabetes Mellitus","Diagnostic Test: ELISA (enzyme-linked immunosorbent assay)","January 3, 2020","Cairo, Cairo, Egypt","https://ClinicalTrials.gov/show/NCT04216654"
123,"NCT04314622","A Study of Supaglutide in Chinese Type 2 Diabetes Patients","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Supaglutide|Drug: Placebo","March 19, 2020","The Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, China","https://ClinicalTrials.gov/show/NCT04314622"
124,"NCT04443842","Behavioural Economics-based Incentives in Adults With Type 2 Diabetes","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Behavioral: Financial and social incentives","June 23, 2020","School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong","https://ClinicalTrials.gov/show/NCT04443842"
125,"NCT04262128","Sedentary Behavior in Older Women With and Without Type 2 Diabetes","Recruiting","No Results Available","Diabetes Mellitus, Type 2|Healthy",,"February 10, 2020","University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States","https://ClinicalTrials.gov/show/NCT04262128"
126,"NCT04342845","Effectiveness of Motivational Interviewing on Improving Care for Patients With Type 2 Diabetes in China","Completed","No Results Available","Diabetes Mellitus, Type 2","Behavioral: Experimental: Motivational interviewing Placebo Comparator: Traditional lectures","April 13, 2020",,"https://ClinicalTrials.gov/show/NCT04342845"
127,"NCT04439474","Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes","Completed","No Results Available","Diabetes Mellitus, Type 2","Drug: Vitamin D3|Drug: Routine treatment","June 19, 2020","Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran, Islamic Republic of","https://ClinicalTrials.gov/show/NCT04439474"
128,"NCT04276428","A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: LY3209590|Drug: Insulin Degludec","February 19, 2020","Yokohama Minoru Clinic, Yokohama, Kanagawa, Japan|P-one clinic, Hachioji, Tokyo, Japan|Clinical Research Hospital, Tokyo, Shinjyuku, Tokyo, Japan","https://ClinicalTrials.gov/show/NCT04276428"
129,"NCT04240171","Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Dapagliflozin 5Mg Tab|Drug: Glimepiride 4Mg Tab","January 27, 2020","Tanta University Hospital, Tanta, El-Gharbia, Egypt","https://ClinicalTrials.gov/show/NCT04240171"
130,"NCT04235959","A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Tirzepatide|Drug: Placebo","January 22, 2020","Peking University First Hospital, Beijing, China","https://ClinicalTrials.gov/show/NCT04235959"
131,"NCT04445181","Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study","Not yet recruiting","No Results Available","Chronic Kidney Disease in Type 2 Diabetes","Drug: The physician's prescription in routine clinical practice","June 24, 2020","A Database, A Database, Canada","https://ClinicalTrials.gov/show/NCT04445181"
132,"NCT04325126","Retinol-binding Protein 4 (RBP4) Metabolizm in Type 2 Diabetes Progression and Associated Cardiovascular Complications","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Other: Exposure factors","March 27, 2020",,"https://ClinicalTrials.gov/show/NCT04325126"
133,"NCT04315688","A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Russia","Enrolling by invitation","No Results Available","Diabetes Mellitus, Type 2","Drug: insulin degludec","March 19, 2020","Novo Nordisk Investigational Site, Dyurtyuli, Russian Federation|Novo Nordisk Investigational Site, Krasnodar, Russian Federation|Novo Nordisk Investigational Site, Krasnoyarsk, Russian Federation|Novo Nordisk Investigational Site, Lyskovo, Russian Federation|Novo Nordisk Investigational Site, Magnitogorsk, Russian Federation|Novo Nordisk Investigational Site, N. Novgorod, Russian Federation|Novo Nordisk Investigational Site, Saint-Petersburg, Russian Federation|Novo Nordisk Investigational Site, Samara, Russian Federation|Novo Nordisk Investigational Site, Saratov, Russian Federation|Novo Nordisk Investigational Site, St. Petersburg, Russian Federation|Novo Nordisk Investigational Site, Ufa, Russian Federation|Novo Nordisk Investigational Site, Vyksa, Russian Federation","https://ClinicalTrials.gov/show/NCT04315688"
134,"NCT04387045","Perceived Stress and Negative Thoughts With Biomarkers in People With Type 2 Diabetes Mellitus and Healthy Subjects","Completed","No Results Available","Diabetes Mellitus, Type 2","Behavioral: Guilty feelings","May 13, 2020","Facultad de medicina De la UADEC Unidad Torreón, Torreón, Coahuila De Zaragoza, Mexico","https://ClinicalTrials.gov/show/NCT04387045"
135,"NCT04227431","A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in China","Enrolling by invitation","No Results Available","Diabetes Mellitus, Type 2","Other: Insulin degludec","January 13, 2020","Novo Nordisk Investigational Site, Langfang, Hebei, China|Novo Nordisk Investigational Site, Kunshan, Jiangsu, China|Novo Nordisk Investigational Site, Nanjing, Jiangsu, China","https://ClinicalTrials.gov/show/NCT04227431"
136,"NCT04237493","Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan","Completed","No Results Available","Diabetes Mellitus, Type 2","Drug: Metformin and Glimepiride (Low Dosage)|Drug: Metformin and Vildagliptin (Low Dosage)|Drug: Metformin and Insulin Glargine U100 (Low Dosage)|Drug: Metformin, Insulin Glargine U100, and Human Regular Insulin (Low Dosage)|Drug: Metformin and Glimepiride (Regular Dosage)|Drug: Metformin and Vildagliptin (Regular Dosage)|Drug: Metformin and Insulin Glargine U100 (Regular Dosage)|Drug: Metformin, Insulin Glargine U100, and Human Regular Insulin (Regular Dosage)","January 23, 2020","Jordan University Hospital, Amman, Amman Governorate, Jordan","https://ClinicalTrials.gov/show/NCT04237493"
137,"NCT04324229","Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes","Recruiting","No Results Available","Gestational Diabetes","Drug: Liraglutide 6 MG/ML [Victoza]|Drug: Placebos","March 27, 2020","Turku University Hospital, Turku, Finland","https://ClinicalTrials.gov/show/NCT04324229"
138,"NCT04416841","Tai Chi Chuan as Rehabilitation Program for Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|Cognitive Dysfunction","Behavioral: Tai Chi Chuan|Behavioral: Fitness Walking|Behavioral: Standard Diabetic Care Education","June 4, 2020","Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China","https://ClinicalTrials.gov/show/NCT04416841"
139,"NCT04262661","A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes","Recruiting","No Results Available","Healthy Volunteers|Diabetes Mellitus, Type 2","Drug: NNC0472-0147|Drug: insulin glargine|Drug: Placebo (NNC0472-0147)","February 10, 2020","Novo Nordisk Investigational Site, Mainz, Germany|Novo Nordisk Investigational Site, Neuss, Germany","https://ClinicalTrials.gov/show/NCT04262661"
140,"NCT04261933","A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)","Enrolling by invitation","No Results Available","Diabetes Mellitus, Type 2","Drug: semaglutide","February 10, 2020","Novo Nordisk Investigational Site, Amberg, Germany|Novo Nordisk Investigational Site, Augsburg, Germany|Novo Nordisk Investigational Site, Bad Mergentheim, Germany|Novo Nordisk Investigational Site, Bad Oeynhausen, Germany|Novo Nordisk Investigational Site, Bautzen, Germany|Novo Nordisk Investigational Site, Berlin, Germany|Novo Nordisk Investigational Site, Berlin, Germany|Novo Nordisk Investigational Site, Berlin, Germany|Novo Nordisk Investigational Site, Berlin, Germany|Novo Nordisk Investigational Site, Bonn, Germany|Novo Nordisk Investigational Site, Bramsche, Germany|Novo Nordisk Investigational Site, Darmstadt, Germany|Novo Nordisk Investigational Site, Dessau-Roßlau, Germany|Novo Nordisk Investigational Site, Dresden, Germany|Novo Nordisk Investigational Site, Dresden, Germany|Novo Nordisk Investigational Site, Duisburg, Germany|Novo Nordisk Investigational Site, Erlangen, Germany|Novo Nordisk Investigational Site, Essen, Germany|Novo Nordisk Investigational Site, Essen, Germany|Novo Nordisk Investigational Site, Fulda, Germany|Novo Nordisk Investigational Site, Gelnhausen, Germany|Novo Nordisk Investigational Site, Grasleben, Germany|Novo Nordisk Investigational Site, Hainburg, Germany|Novo Nordisk Investigational Site, Halle (Saale), Germany|Novo Nordisk Investigational Site, Hamburg, Germany|Novo Nordisk Investigational Site, Hammelburg, Germany|Novo Nordisk Investigational Site, Hannover, Germany|Novo Nordisk Investigational Site, Heidenheim an der Brenz, Germany|Novo Nordisk Investigational Site, Herrenberg, Germany|Novo Nordisk Investigational Site, Hof, Germany|Novo Nordisk Investigational Site, Hohenmölsen, Germany|Novo Nordisk Investigational Site, Jena, Germany|Novo Nordisk Investigational Site, Köln, Germany|Novo Nordisk Investigational Site, Lichtenfels, Germany|Novo Nordisk Investigational Site, Lingen, Germany|Novo Nordisk Investigational Site, Ludwigsburg, Germany|Novo Nordisk Investigational Site, Magdeburg, Germany|Novo Nordisk Investigational Site, Marburg, Germany|Novo Nordisk Investigational Site, Marburg, Germany|Novo Nordisk Investigational Site, Meckesheim, Germany|Novo Nordisk Investigational Site, Mössingen, Germany|Novo Nordisk Investigational Site, Mühldorf Am Inn, Germany|Novo Nordisk Investigational Site, Mülheim, Germany|Novo Nordisk Investigational Site, München, Germany|Novo Nordisk Investigational Site, München, Germany|Novo Nordisk Investigational Site, Münster, Germany|Novo Nordisk Investigational Site, Neustrelitz, Germany|Novo Nordisk Investigational Site, Osnabrück, Germany|Novo Nordisk Investigational Site, Rellingen, Germany|Novo Nordisk Investigational Site, Saint Ingbert-Oberwürzbach, Germany|Novo Nordisk Investigational Site, Schorndorf, Germany|Novo Nordisk Investigational Site, Schwerin, Germany|Novo Nordisk Investigational Site, Sonsbeck, Germany|Novo Nordisk Investigational Site, Straubing, Germany|Novo Nordisk Investigational Site, Stuttgart, Germany|Novo Nordisk Investigational Site, Stuttgart, Germany|Novo Nordisk Investigational Site, Trier, Germany|Novo Nordisk Investigational Site, Villingen-Schwenningen, Germany|Novo Nordisk Investigational Site, Villingen-Schwenningen, Germany|Novo Nordisk Investigational Site, Wedemark, Germany|Novo Nordisk Investigational Site, Wetzlar, Germany|Novo Nordisk Investigational Site, Wiesloch, Germany|Novo Nordisk Investigational Site, Witzenhausen, Germany|Novo Nordisk Investigational Site, Wolmirstedt, Germany|Novo Nordisk Investigational Site, Wurzen, Germany|Novo Nordisk Investigational Site, Zwenkau, Germany","https://ClinicalTrials.gov/show/NCT04261933"
141,"NCT04226105","Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients","Active, not recruiting","No Results Available","Diabetes Mellitus, Type 2|Diabetes Mellitus","Drug: GP40081|Drug: NovoMix 30","January 13, 2020","Arkhangelsk Regional Clinical Hospital, Arkhangel'sk, Russian Federation|Kazan Endocrinology Dispensary, Kazan, Russian Federation|Krasnoyarsk State Medical University named after Professor V.F. Voino-Yasenetsky, Krasnoyarsk, Russian Federation|V.A. Baranov Republic Hospital, Petrozavodsk, Russian Federation|City Diagnostic Center № 1, Saint Petersburg, Russian Federation|City Hospital № 2, Saint Petersburg, Russian Federation|City Polyclinic № 117, Saint Petersburg, Russian Federation|EosMed, Saint Petersburg, Russian Federation|Institute of Medical Research, Saint Petersburg, Russian Federation|Research Center Eco-Safety, Saint Petersburg, Russian Federation|Almazov National Medical Research Centre, Saint Petersburg, Russian Federation|Pokrovskaya Municipal Hospital, Saint Petersburg, Russian Federation|Diabetes Center, Samara, Russian Federation|Volgograd Region Clinical Hospital №1, Volgograd, Russian Federation","https://ClinicalTrials.gov/show/NCT04226105"
142,"NCT04364685","Effect of Walking on Sand With Dietary Intervention in Overweight Type 2 Diabetes Mellitus Patients.","Completed","No Results Available","Walking, Difficulty|Diabetes Mellitus, Type 2|Hemoglobin; Hb-SC","Other: Walking on soft-sand|Other: Walking on Levelled Surface","April 28, 2020","King Khalid Hospital, Al Majma'ah, Riyadh, Saudi Arabia","https://ClinicalTrials.gov/show/NCT04364685"
143,"NCT04259606","Effect of Cassia Cinnamon on Arterial Stiffness Parameters in Patients With Type 2 Diabetes Mellitus","Recruiting","No Results Available","Arterial Stiffness","Dietary Supplement: Cassia Cinnamon|Other: Calcined magnesia","February 6, 2020","Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco, Mexico","https://ClinicalTrials.gov/show/NCT04259606"
144,"NCT04241575","Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages","Recruiting","No Results Available","Fatty Liver, Nonalcoholic|Diabetes Mellitus, Type 2","Diagnostic Test: Simple fibrosis scores and electronic reminder messages","January 27, 2020","Prince of Wales Hospital, Hong Kong, Hong Kong","https://ClinicalTrials.gov/show/NCT04241575"
145,"NCT04281186","Retinal and Cognitive Dysfunction in Type 2 Diabetes","Not yet recruiting","No Results Available","Retinal Function|Cognitive Dysfunction|Microperimetry",,"February 24, 2020",,"https://ClinicalTrials.gov/show/NCT04281186"
146,"NCT04446754","The Genetic Effects of rs7903146 and Dietary Intake on Type 2 Diabetes Mellitus Risk in a Healthy Population","Completed","No Results Available","Health Behavior|Blood Glucose, High|Diet Habit|Genetic Predisposition",,"June 25, 2020","St Marys University, London, United Kingdom","https://ClinicalTrials.gov/show/NCT04446754"
147,"NCT04411342","Normoalbuminuric Chronic Kidney Disease in Type 2 Diabetes","Not yet recruiting","No Results Available","Chronic Kidney Diseases","Diagnostic Test: Albumin creatinine ratio","June 2, 2020",,"https://ClinicalTrials.gov/show/NCT04411342"
148,"NCT04287179","SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Semaglutide","February 27, 2020","Novo Nordisk Investigational Site, Buena Park, California, United States|Novo Nordisk Investigational Site, Fresno, California, United States|Novo Nordisk Investigational Site, San Jose, California, United States|Novo Nordisk Investigational Site, Walnut Creek, California, United States|Novo Nordisk Investigational Site, Waterbury, Connecticut, United States|Novo Nordisk Investigational Site, Honolulu, Hawaii, United States|Novo Nordisk Investigational Site, Idaho Falls, Idaho, United States|Novo Nordisk Investigational Site, Indianapolis, Indiana, United States|Novo Nordisk Investigational Site, Troy, Michigan, United States|Novo Nordisk Investigational Site, Albany, New York, United States|Novo Nordisk Investigational Site, West Seneca, New York, United States|Novo Nordisk Investigational Site, Dallas, Texas, United States|Novo Nordisk Investigational Site, Round Rock, Texas, United States|Novo Nordisk Investigational Site, Sugar Land, Texas, United States|Novo Nordisk Investigational Site, Graz, Austria|Novo Nordisk Investigational Site, Stockerau, Austria|Novo Nordisk Investigational Site, Wien, Austria|Novo Nordisk Investigational Site, Wien, Austria|Novo Nordisk Investigational Site, Jyväskylä, Finland|Novo Nordisk Investigational Site, Kuopio, Finland|Novo Nordisk Investigational Site, Lahti, Finland|Novo Nordisk Investigational Site, Raisio, Finland|Novo Nordisk Investigational Site, Seinäjoki, Finland|Novo Nordisk Investigational Site, Göteborg, Sweden|Novo Nordisk Investigational Site, Malmö, Sweden","https://ClinicalTrials.gov/show/NCT04287179"
149,"NCT04254016","Short Term Effects of a Hibiscus Sabdariffa and Stevia Rebaudiana Drink on Cardiac Relaxation and Urinary Albumin Excretion in a Group of Diabetic Type 2 Subjects","Completed","No Results Available","Benefits of a Hibiscus Sabdariffa and Stevia Rebaudiana Drink in Patients With Type 2 Diabetes Mellitus Before and After 8 Weeks of add-on Therapy","Dietary Supplement: HIBISTEVER1","February 5, 2020","Yaounde Central Hospital, NAtional Obesity Center, Yaounde, Cameroon","https://ClinicalTrials.gov/show/NCT04254016"
150,"NCT04276051","Cryovagotomy Diabetes Trial","Not yet recruiting","No Results Available","Diabete Type 2|Diabetes Mellitus|Obesity","Device: Visual-ICE Cryoablation System|Behavioral: Lifestyle Intervention","February 19, 2020","Emory University Hospital, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT04276051"
151,"NCT04281069","Diabetes Type 2 in the Eastern Region of Morocco","Recruiting","No Results Available","Quality of Life|Diabetes Mellitus, Type 2|Adherence, Medication|Diet Habit",,"February 24, 2020","Université Mohammed Premier Oujda (UMP) Faculté des Sciences, Département de Biologie, Oujda, Oujda Angad, Morocco","https://ClinicalTrials.gov/show/NCT04281069"
152,"NCT04256304","The Effect of The Personalized Patient Engagement Plan on Diabetes Management","Recruiting","No Results Available","Type 2 Diabetes|Patient Engagement|Self Efficacy|Adherence, Patient","Behavioral: PHEinAction-Personalized Patient Engagement Plan","February 5, 2020","Hacettepe University Faculty of Nursing, Ankara, Turkey|Hacettepe University, Ankara, Turkey","https://ClinicalTrials.gov/show/NCT04256304"
153,"NCT04234763","Postprandial Metabolites of Meal Challenge Test in Diabetes State","Enrolling by invitation","No Results Available","Type2 Diabetes|Postprandial Hyperglycemia","Behavioral: Strategies to lower postprandial hyperglycemia in T2D patients|Behavioral: Control group","January 21, 2020","Universiti Putra Malaysia, Serdang, Selangor, Malaysia","https://ClinicalTrials.gov/show/NCT04234763"
154,"NCT04416204","Effect of High Carbohydrate vs. Low Carbohydrate Diet in Type 2 Diabetes","Not yet recruiting","No Results Available","Diabetes Mellitus|Diabetes Mellitus, Type 2","Other: High Carbohydrate (glycogen loading)|Other: Low carbohydrate (No Glycogen Loading)","June 4, 2020","University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT04416204"
155,"NCT04442451","Mechanisms of Fatigability With Pre-Diabetes","Not yet recruiting","No Results Available","Pre-diabetes|Type 2 Diabetes","Other: Control Exercise|Other: Blood Flow Restriction Exercise","June 22, 2020",,"https://ClinicalTrials.gov/show/NCT04442451"
156,"NCT04319003","Pilot Sugar Reduction Intervention in Kiritimati Teenagers","Completed","No Results Available","Type 2 Diabetes|Obesity","Behavioral: Sugar-reduction intervention","March 24, 2020","University of Southern California, Los Angeles, California, United States|Kiritimati, London Village, Kiribati","https://ClinicalTrials.gov/show/NCT04319003"
157,"NCT04214704","Assessing the Benefits of a Painless Lancing Device Among Diabetes Patients","Recruiting","No Results Available","Type 1 Diabetes|Type 2 Diabetes","Device: Genteel lancing device|Device: Conventional lancing device","January 2, 2020","Jothydev's Diabetes Research Center, Trivandrum, Kerala, India","https://ClinicalTrials.gov/show/NCT04214704"
158,"NCT04222894","Hospital Workplace Nutrition Study","Recruiting","No Results Available","Overweight|Type2 Diabetes","Other: Plant-based diet|Other: Control Diet","January 10, 2020","Sibley Memorial Hospital, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT04222894"
159,"NCT04447859","16-week Flexible vs. 8-week Semaglutide Titration","Recruiting","No Results Available","Diabetes type2","Drug: Semaglutide|Other: label recommended titration","June 25, 2020","Tel-Aviv Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT04447859"
160,"NCT04436822","Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics","Not yet recruiting","No Results Available","Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus","Device: Continuous Glucose Monitoring","June 18, 2020","AMCR Institute, Escondido, California, United States|Sansum Diabetes Research Institute, Santa Barbara, California, United States|SoCal Diabetes, Torrance, California, United States|Diablo Clinical Research, Inc., Walnut Creek, California, United States|Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States|Barbara Davis Center for Diabetes, Aurora, Colorado, United States|University of South Florida, Tampa, Florida, United States|Atlanta Diabetes Associates, Atlanta, Georgia, United States|Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls, Idaho, United States|AM Diabetes and Endocrinology Center, Bartlett, Tennessee, United States|Texas Diabetes & Endocrinology, Austin, Texas, United States|University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States|Rainier Clinical Research Center, Inc., Renton, Washington, United States","https://ClinicalTrials.gov/show/NCT04436822"
161,"NCT04378114","Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults","Recruiting","No Results Available","Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus","Device: One time acetaminophen ingestion while wearing Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter","May 7, 2020","AMCR Institue, Escondido, California, United States|Sansum Diabetes Research Institute, Santa Barbara, California, United States|Diablo Clinical Research, Walnut Creek, California, United States|Barbara Davis Center - Adults, Aurora, Colorado, United States|""Atlanta Diabetes Associates, Atlanta, Georgia, United States|Rainier Clinical Research Center, Inc., Renton, Washington, United States","https://ClinicalTrials.gov/show/NCT04378114"
162,"NCT04283617","Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study","Not yet recruiting","No Results Available","Diabete Type 2","Behavioral: Intensification of insulin regimen/Nutrition","February 25, 2020","Yale New Haven Hospital, New Haven, Connecticut, United States","https://ClinicalTrials.gov/show/NCT04283617"
163,"NCT04230382","The Proportion of Patients With Non-diagnosed Diabetes Type 2","Enrolling by invitation","No Results Available","Diabetes Mellitus, Type 2","Diagnostic Test: Diagnosis of diabetes (OGTT)","January 18, 2020","National Institute of Public Health, Slovenia, Ljubljana, Slovenia","https://ClinicalTrials.gov/show/NCT04230382"
164,"NCT04332354","Glycemic Profile by CGMS in Diabetic Patients After Bariatric Surgery","Completed","No Results Available","Type 2 Diabetes Mellitus in Obese|Bariatric Surgery Candidate","Other: routine care. No intervention","April 2, 2020",,"https://ClinicalTrials.gov/show/NCT04332354"
165,"NCT04441216","Effects of TCM on Beta-cell Function and Insulin Resistance in High Risk Chinese Individuals for T2D (TCM_PDiab_P01)","Not yet recruiting","No Results Available","Prediabetic State","Other: Rhizoma Coptidis, Radix Astragali and Flos Lonicerae|Other: Rhizoma Coptidis, Radix Astragali and Flos Lonicerae, Ophiopogonis Radix","June 22, 2020",,"https://ClinicalTrials.gov/show/NCT04441216"
166,"NCT04217902","VOIES-D-ql - Qualitative Study on Experiences of Diabetes Care Delivery and Planning","Not yet recruiting","No Results Available","Diabete Type 1|Diabete Type 2","Other: Description of patients' experiences of diabetes care delivery and planning|Other: Description of health care professionals needs and experiences in diabetes care delivery and planning","January 6, 2020",,"https://ClinicalTrials.gov/show/NCT04217902"
167,"NCT04233658","Cynara Scolymus Extract for Treatment of Diabetes Mellitus Type 2","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Placebo|Drug: Cynara Scolymus","January 18, 2020",,"https://ClinicalTrials.gov/show/NCT04233658"
168,"NCT04271631","Integration of Education Based-Application and ""CARE Coaching Model"" in Management of Type 2 Diabetes Mellitus Patients Using Insulin","Active, not recruiting","No Results Available","Diabetes Mellitus, Type 2","Other: Mobile Application-Based Diabetes Education|Other: Health Coaching","February 17, 2020","Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, DKI Jakarta, Indonesia","https://ClinicalTrials.gov/show/NCT04271631"
169,"NCT04216875","Best Practice Study of Diabetes Type 2 Management in Primary Care in Switzerland","Active, not recruiting","No Results Available","Diabetes Mellitus, Type 2|Primary Care","Procedure: Best Practice Diabetes Management in Primary Care","January 3, 2020","Hausarztmedizin KSSG, Saint Gallen, SG, Switzerland","https://ClinicalTrials.gov/show/NCT04216875"
170,"NCT04270097","Genetic and Epigenetic Risk of T2D in the UAE","Recruiting","No Results Available","Diabetes Mellitus, Type 2|Obesity",,"February 17, 2020","Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates","https://ClinicalTrials.gov/show/NCT04270097"
171,"NCT04323189","Effects of Sitagliptin in Individuals With Genetically Decreased DPP4","Suspended","No Results Available","Genetics Disease|Type2 Diabetes|Heart Failure","Drug: Sitagliptin 100mg|Drug: Placebo Oral Tablet","March 26, 2020","University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04323189"
172,"NCT04361097","Fecal Microbiota Transplantation as a Therapeutic Strategy in the Progression of Chronic Kidney Disease","Completed","No Results Available","Chronic Kidney Disease Due to Hypertension|Chronic Kidney Disease Due to Type 2 Diabetes Mellitus","Biological: Faecal microbiota transplant|Biological: Placebo","April 24, 2020","Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon, Mexico","https://ClinicalTrials.gov/show/NCT04361097"
173,"NCT04283942","Effect of Intermittent Calorie Restriction on NAFLD Patients With Disorders of Glucose Metabolism","Not yet recruiting","No Results Available","Non-Alcoholic Fatty Liver Disease (NAFLD)|Disorders of Glucose Metabolism|Type 2 Diabetes|Impaired Glucose Regulation","Behavioral: Intermittent caloric restriction|Behavioral: 25kcal/kg/d diet","February 25, 2020","Zhongshan Hospital, Fudan University, Shanghai, China","https://ClinicalTrials.gov/show/NCT04283942"
174,"NCT04377321","Colchicine Has Anti-diabetic Effect","Completed","No Results Available","Treatment Adherence","Drug: Colchicine Tablets","May 6, 2020","Mahmoud Younis, Cairo, Egypt","https://ClinicalTrials.gov/show/NCT04377321"
175,"NCT04424888","Evaluating Use of Continuous Glucose Monitors in a Short-term 2x2-Crossover Study","Completed","No Results Available","Diabetes Type 2|Diabetes Mellitus","Other: WB-011|Other: Placebo|Device: Continuous Glucose Monitor","June 11, 2020","Pendulum Therapeutics Inc, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT04424888"
176,"NCT04448262","Bronchial Asthma and Diabetes: Impact on Bronchial Inflammation and Exercise Capacity","Recruiting","No Results Available","Asthma|Diabete Type 2","Other: data collection","June 25, 2020","Istituti Clinici Maugeri Pneumologia, Tradate, Lombardia, Italy","https://ClinicalTrials.gov/show/NCT04448262"
177,"NCT04429958","The Belgian Diabetes in Pregnancy Follow-up Study","Not yet recruiting","No Results Available","Gestational Diabetes|Type2 Diabetes|Obesity","Other: GDM","June 12, 2020","OLV-Alast, Aalst, Belgium|UZA, Antwerp, Belgium|OLV-Asse, Asse, Belgium|Imelda Bonheiden, Bonheiden, Belgium","https://ClinicalTrials.gov/show/NCT04429958"
178,"NCT04440449","Effect of Behavioral Lifestyle Intervention on Frailty in Older Adults With Diabetes","Recruiting","No Results Available","Frailty|Weight, Body|Type 2 Diabetes","Behavioral: Lifestyle App","June 19, 2020","The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT04440449"
179,"NCT04416503","Effect of Reflexology on Diabetic Foot and Glycemic Control in Elderly Diabetic Individuals","Completed","No Results Available","Reflexology|Type 2 Diabetes|Older People","Other: Foot reflexology","June 4, 2020","Bolu Elderly Health Center, Bolu, Turkey","https://ClinicalTrials.gov/show/NCT04416503"
180,"NCT04326192","Brown Adipose Tissue Activation by Spinal Cord Stimulation","Not yet recruiting","No Results Available","Pain, Back|Obesity, Morbid|Type 2 Diabetes","Device: Research electrode","March 30, 2020","Oregon Health & Science University, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT04326192"
181,"NCT04382521","A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions","Not yet recruiting","No Results Available","Hyperlipemia|Hypertension|Type2 Diabetes","Behavioral: Text Message Intervention","May 11, 2020",,"https://ClinicalTrials.gov/show/NCT04382521"
182,"NCT04289753","Behavioral Economics Applications to Geriatrics Leveraging EHRs R33 Trial","Not yet recruiting","No Results Available","Prostate Specific Antigen Screening|Asymptomatic Bacteriuria|Type 2 Diabetes","Behavioral: EHR clinical decision support nudges|Behavioral: Brief clinician education","February 28, 2020","Northwestern Medicine, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT04289753"
183,"NCT04429503","Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease","Not yet recruiting","No Results Available","Diabetic Macular Edema|Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus","Drug: aflibercept|Drug: High-dose aflibercept","June 12, 2020",,"https://ClinicalTrials.gov/show/NCT04429503"
184,"NCT04383041","Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Other: No intervention","May 11, 2020","Many locations, Multiple Locations, Germany","https://ClinicalTrials.gov/show/NCT04383041"
185,"NCT04233801","A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Empagliflozin|Drug: Placebo","January 18, 2020","Beijing Pinggu Hospital, Beijing, China|Jiangxi Provincial People's Hospital, Nanchang, China|The First Affiliated Hospital of Nanchang University, Nanchang, China|Suzhou Municipal Hospital, Suzhou, China|The First Affiliated Hospital of Soochow University, Suzhou, China","https://ClinicalTrials.gov/show/NCT04233801"
186,"NCT04380584","Relation Between Plasma Apelin Level and Diabetic Nephropathy in Type 2 Diabetes Patients.","Completed","No Results Available","Diabetic Nephropathies","Diagnostic Test: plasma Apelin level","May 8, 2020","Cairo university hospitals, Cairo, Manial, Egypt","https://ClinicalTrials.gov/show/NCT04380584"
187,"NCT04423302","Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)","Not yet recruiting","No Results Available","Prediabetic State|Diabetes type2|Dysglycemia","Dietary Supplement: TOTUM-63 3 intakes per day|Dietary Supplement: Placebo 3 intakes per day|Dietary Supplement: TOTUM-63 2 intakes per day","June 9, 2020","CHU Amiens, Amiens, France|CH Arras, Arras, France|CIC Clermont Ferrand, Clermont-Ferrand, France|CEN Nutriment, Dijon, France|CHU Dijon, Dijon, France|Eurofins Optimed, Gières, France|CHU Grenoble, Grenoble, France|Institut Pasteur de Lille, Lille, France|CHU Lille, Lille, France|CHU Nantes, Nantes, France|CHU Nice, Nice, France|Unité de Recherche Clinique en Immunologie Lyon Sud, Pierre-Bénite, France|CHU Rouen, Rouen, France|Biofortis Mérieux NutriSciences, Saint-Herblain, France|Analyze & Realize, Berlin, Germany|Biotesys, Esslingen, Germany","https://ClinicalTrials.gov/show/NCT04423302"
188,"NCT04239586","Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes","Enrolling by invitation","No Results Available","Maturity-Onset Diabetes of the Young, Type 3|Maturity Onset Diabetes of the Young, Type 1|Childhood Diabetes Mellitus|Insulin-dependent Diabetes Mellitus","Drug: Sulfonylurea","January 27, 2020","Department of Pediatrics and Adolescents, Haukeland University Hospital, and Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway","https://ClinicalTrials.gov/show/NCT04239586"
189,"NCT04345497","Diabetes-Specific Formula on Long Term Glycemic Control","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Other: Diabetes-Specific Formula|Other: Standard Of Care","April 14, 2020","Hospital Canselor Tuanku Mukhriz, Universiti Kebangsaan Malaysia Medical Center, Kuala Lumpur, Malaysia|International Medical University, Kuala Lumpur, Malaysia|Klinik Kesihatan Seremban, Seremban, Malaysia|Phramongkutklao Hospital, Bangkok, Thailand|Rajavithi Hospital, Bangkok, Thailand","https://ClinicalTrials.gov/show/NCT04345497"
190,"NCT04326166","Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Evogliptin|Drug: Metformin and Evogliptin","March 30, 2020","Sanggye paik pospital, Seoul, Nowon-gu, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04326166"
191,"NCT04219462","Effect of ESWT on ED in Type 2 Diabetics","Recruiting","No Results Available","Erectile Dysfunction|Diabetes Mellitus, Type 2","Device: active extracorporeal shock wave|Device: sham extracorporeal shock wave","January 7, 2020","Faculty of Physical Therapy, Giza, Egypt","https://ClinicalTrials.gov/show/NCT04219462"
192,"NCT04298229","Efficacy and Safety of Dapagliflozin in Acute Heart Failure","Recruiting","No Results Available","Heart Failure|Diabetes Mellitus, Type 2","Drug: Dapagliflozin 10 MG|Other: Protocolized Diuretic Therapy","March 6, 2020","University of Mississippi Medical Center, Jackson, Mississippi, United States|TriStar Centennial Medical Center, Nashville, Tennessee, United States|Saint Thomas West Hospital, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT04298229"
193,"NCT04284943","Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery","Recruiting","No Results Available","Gastric Cancer|Diabetes Mellitus, Type 2","Procedure: Long limb Roux-en-Y reconstruction after subtotal gastrectomy|Procedure: Conventional Roux-en-Y reconstruction after subtotal gastrectomy|Procedure: Billroth II reconstruction after subtotal gastrectomy","February 26, 2020","Korea University Anam Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04284943"
194,"NCT04231838","Metabolic Syndrome in Diabetic Smokers Using Cigarettes & Combustion-Free Nicotine Delivery Systems","Not yet recruiting","No Results Available","Cardiovascular Risk Factor|Diabetes Mellitus, Type 2","Other: TOBACCO CIGARETTES|Other: COMBUSTION-FREE NICOTINE DELIVERY SYSTEMS (C-F NDS)","January 18, 2020","Ashford and St Peters NHS Foundation Trust, Chertsey, Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT04231838"
195,"NCT04407234","A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide","Not yet recruiting","No Results Available","Overweight|Obesity|Diabetes Mellitus, Type 2","Drug: Tirzepatide|Drug: Acetaminophen","May 29, 2020","Clinical Pharmacology of Miami, Hialeah, Florida, United States","https://ClinicalTrials.gov/show/NCT04407234"
196,"NCT04255238","A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Gemigliptin 50mg|Drug: Dapagliflozin 10mg","February 5, 2020",,"https://ClinicalTrials.gov/show/NCT04255238"
197,"NCT04238702","Renohemodynamic Effects of Combined empagliflOzin and LosARtan","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|Diabetic Kidney Disease","Drug: Empagliflozin 10 MG|Drug: Losartan 50Mg Tab|Other: Placebo","January 23, 2020",,"https://ClinicalTrials.gov/show/NCT04238702"
198,"NCT04350879","Diabetes Mellitus and Pregnancy : Knowledge Assessment","Recruiting","No Results Available","Diabetes Mellitus","Other: Data record","April 17, 2020","Damien JOLLY, Reims, France","https://ClinicalTrials.gov/show/NCT04350879"
199,"NCT04438018","Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM (DIA-LINK2)","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|Depressive Symptoms|Stress, Psychological|Glucose, High Blood",,"June 18, 2020","Research Institute of the Diabetes Academy Mergentheim, Diabetes Center Mergentheim, Bad Mergentheim, Baden-Wuerttemberg, Germany","https://ClinicalTrials.gov/show/NCT04438018"
200,"NCT04243850","REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|Chronic Kidney Diseases","Drug: Empagliflozin 10 MG|Drug: Placebo oral tablet|Diagnostic Test: Caffeine","January 28, 2020",,"https://ClinicalTrials.gov/show/NCT04243850"
201,"NCT04230889","Evaluation of Glucose Control in Patients With Diabetes","Completed","No Results Available","Glycemic Control","Other: Usual Diet Group|Other: Group 1 Nutritional Shake|Other: Group 2 Nutritional Shake","January 18, 2020","Radiant Research, Scottsdale, Arizona, United States|MB Clinical Research, Boca Raton, Florida, United States|Radiant Clinical Research, Pinellas Park, Florida, United States|Rocky Mountain Daibetes and Osteoporosis Center, Idaho Falls, Idaho, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Joslin Diabetes Center, Boston, Massachusetts, United States|Health Partners Institute, International Diabetes Center, Minneapolis, Minnesota, United States|Radiant Research, Inc., Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT04230889"
202,"NCT04375943","Clinical and Echocardiographic Management of Patients With Heart Failure and Diabetes: SCODIAC Follow up Study","Completed","No Results Available","Diabetes|Heart Failure","Drug: Antidiabetic","May 6, 2020","Federico II University, Naples, Italy","https://ClinicalTrials.gov/show/NCT04375943"
203,"NCT04377399","High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy","Completed","No Results Available","Diabetes Type 2|Diabetic Neuropathies|Vitamin D Deficiency","Drug: Vitamin D","May 6, 2020","Almazov National Medical Research Centre, Saint Petersburg, Russian Federation","https://ClinicalTrials.gov/show/NCT04377399"
204,"NCT04265469","Mobile Application For Educating Diabetics About Foot Care","Completed","No Results Available","Diabetic Foot, Mobile Application, Patient Education","Other: Diabetic foot education","February 11, 2020",,"https://ClinicalTrials.gov/show/NCT04265469"
205,"NCT04304560","Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial","Not yet recruiting","No Results Available","Heart Failure With Reduced Ejection Fraction (HFrEF)|Diabete Type 2|Cardiomyopathies","Drug: Dapagliflozin 10 MG|Drug: Placebo oral tablet","March 11, 2020",,"https://ClinicalTrials.gov/show/NCT04304560"
206,"NCT04306406","Molecular Mechanisms of Raspberries Effect on Insulin Resistance and Inflammation","Completed","No Results Available","Inflammation|Insulin Resistance","Other: Raspberries","March 12, 2020",,"https://ClinicalTrials.gov/show/NCT04306406"
207,"NCT04242758","Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy","Active, not recruiting","No Results Available","Renal Function Disorder|Glucose Metabolism Disorders","Drug: Dapagliflozin 10 MG|Drug: Hydrochlorothiazide 12.5mg","January 27, 2020","University of Pisa, Pisa, Italy","https://ClinicalTrials.gov/show/NCT04242758"
208,"NCT04436666","Virtual Reality, Ice Application and Self-injection and Self-test Fair, Pain and State Anxiety","Not yet recruiting","No Results Available","Injection Site Irritation|Fear of Pain","Device: motivational video production through virtual reality glasses|Other: Ice Application","June 18, 2020","seher ÇEVİK, Malatya, Turkey","https://ClinicalTrials.gov/show/NCT04436666"
209,"NCT04287439","Relaxation and Meditation Techniques on Pain, Fatigue and Quality of Life","Completed","No Results Available","Neuropathy, Diabetic","Behavioral: Progressive muscle relaxation|Behavioral: Mindfulness meditation|Other: Attention matched control","February 27, 2020","Ankara University Medical Faculty Ibni Sina Hospital Endocrinology Outpatient Unit, Ankara, Turkey","https://ClinicalTrials.gov/show/NCT04287439"
210,"NCT04361799","Perioperative Closed-loop Glucose Control","Not yet recruiting","No Results Available","Perioperative Hyperglycaemia|Insulin Therapy|Elective Surgery|Closed-Loop Glucose Control|Artificial Pancreas","Device: CamAPS|Drug: Standard insulin therapy","April 24, 2020","Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital, Bern, Switzerland","https://ClinicalTrials.gov/show/NCT04361799"
211,"NCT04306848","Temporary Use of a Continuous Glucose Monitoring System as an Adjunct to Lifestyle Medicine Education","Not yet recruiting","No Results Available","Blood Glucose Profile","Device: Temporary Continuous Glucose Monitoring System","March 13, 2020",,"https://ClinicalTrials.gov/show/NCT04306848"
212,"NCT04257409","Musculoskeletal Changes After Physiotherapeutic Intervention in Podiatric Subjects","Recruiting","No Results Available","Prevention of Diabetic Foot","Other: Physical intervention by exercise","February 6, 2020","Institute for Clinical and Experimental Medicine, Prague, Czechia","https://ClinicalTrials.gov/show/NCT04257409"
213,"NCT04288778","A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes","Not yet recruiting","No Results Available","Diabetes Mellitus","Drug: Canagliflozin + Metformin hydrochloride (Fixed Dose Combination)","February 28, 2020","Belgaum Diabetes Centre, Belgaum, India|Lifecare Hospital and Research Centre, Bengaluru, India|Kovai Diabetes Specialty Centre & Hospital, Coimbatore, India|Thumbay Hospital New life / Endocrinology, Hyderabad, India|Arthur Asirvatham Hospital, Madurai, India|Seth G. S. Medical College and KEM Hospital, Mumbai, India|Jehangir Clinical Development Center Pvt Ltd, Pune, India|Chellaram Diabetes Institute, Pune, India|Nirmal Hospital Pvt. Ltd., Surat, India|Jothydev's Diabetes Research Centre, Trivandrum, India","https://ClinicalTrials.gov/show/NCT04288778"
214,"NCT04284722","Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery","Not yet recruiting","No Results Available","Hyperglycemia|Metformin|Type 2 Diabetes|Hyperlactatemia","Drug: Metformin Hydrochloride","February 26, 2020",,"https://ClinicalTrials.gov/show/NCT04284722"
215,"NCT04392557","Anti-inflammatory Status in DM2 Treated Patients","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Metformin / alogliptin Oral Product|Drug: Metformin / Pioglitazone Pill|Drug: triple therapy","May 19, 2020","Azienda Sanitaria Provinciale, Catanzaro, Italy","https://ClinicalTrials.gov/show/NCT04392557"
216,"NCT04293731","Smectite Gel and Probiotic for Obesity and Insulin Resistance","Completed","No Results Available","Obesity|Insulin Resistance|Insulin Sensitivity|Type2 Diabetes Mellitus|Visceral Obesity","Dietary Supplement: Symbiter-Smectite|Dietary Supplement: Placebo","March 3, 2020","Bogomolets National Medical University, Kyiv, Ukraine","https://ClinicalTrials.gov/show/NCT04293731"
217,"NCT04313920","Study of a Carbohydrate Drink in Adults","Recruiting","No Results Available","Glycemic Response","Other: Nutritional Supplement","March 18, 2020","Health Awareness, Inc., Jupiter, Florida, United States|Biofortis, Addison, Illinois, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT04313920"
218,"NCT04369001","Program ACTIVE: Phase 2","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|Depression","Behavioral: Community-Based Exercise|Behavioral: Cognitive Behavioral Therapy","April 30, 2020",,"https://ClinicalTrials.gov/show/NCT04369001"
219,"NCT04245826","Meta-analysis of Low-calorie Sweetened Beverages and Cardiometabolic Outcomes","Active, not recruiting","No Results Available","Adiposity|Metabolic Syndrome|Type 2 Diabetes|Cardiovascular Diseases|Mortality","Other: Change in LCSBs Intake|Other: Substitute LCSBs for SSBs or Water","January 29, 2020","Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04245826"
220,"NCT04286555","Dietary Approaches to Stop Hypertension for Diabetes","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|Diabetes|Diabetes type2|Type2 Diabetes|Type 2 Diabetes|Type II Diabetes|Hypertension|High Blood Pressure","Other: DASH4D diet|Other: comparison diet|Other: higher sodium|Other: lower sodium","February 27, 2020","Johns Hopkins ProHealth, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT04286555"
221,"NCT04403945","The Predictive Value of Sidestream Dark Field Imaging in Diabetic Nephropathy","Recruiting","No Results Available","Microcirculation Detection in Diabetic Patients","Device: Sidestream dark field(SDF) imagining","May 27, 2020","The third hospital affiliated to the Third Military Medical University, Chongqing, Chongqing, China","https://ClinicalTrials.gov/show/NCT04403945"
222,"NCT04331535","The Genomic Medicine at VA Study","Recruiting","No Results Available","Coronary Artery Disease|Atrial Fibrillation|Type 2 Diabetes|Colorectal Cancer|Breast Cancer|Prostate Cancer","Diagnostic Test: Polygenic risk score (PRS)","April 2, 2020","VA Boston Healthcare System, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04331535"
223,"NCT04356898","Ramadan Flash Glucose Monitoring Study","Completed","No Results Available","Diabetes Mellitus","Other: No intervention","April 22, 2020","Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates|Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates","https://ClinicalTrials.gov/show/NCT04356898"
224,"NCT04327713","Meta-analysis of Fish Oil Supplementation and Cardiovascular Outcomes in Diabetes","Active, not recruiting","No Results Available","Type2 Diabetes|Heart Failure|Myocardial Infarction|Stroke|Arrhythmia|Cardiovascular Diseases","Dietary Supplement: fish oil supplement","March 31, 2020","Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04327713"
225,"NCT04406792","Alternative Lifestyle Interventions in Vulnerable Ethnic Groups","Not yet recruiting","No Results Available","Gestational Diabetes|Pre-Eclampsia|Type2 Diabetes|Chronic Hypertension Complicating Pregnancy|Primary Hypertension After Pregnancy|Obesity","Behavioral: Alternative Lifestyle Interventions in Vulnerable Ethnic groups|Behavioral: Diabetes Prevention Program (DPP) online|Behavioral: Standard of Care","May 28, 2020","Vanderbilt University Medical Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT04406792"
226,"NCT04437485","eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk","Enrolling by invitation","No Results Available","Depression|Major Depressive Disorder|Dysthymic Disorder|Depressive Symptoms|Type 2 Diabetes|PreDiabetes|Insulin Resistance","Behavioral: Beating the Blues US™ (BtB)|Behavioral: Problem Solving Treatment in Primary Care (PST-PC)|Drug: Antidepressant Medications|Other: Active Control","June 18, 2020","IUPUI Department of Psychology, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT04437485"
227,"NCT04442334","The European NAFLD Registry","Recruiting","No Results Available","NAFLD|NASH|NASH - Nonalcoholic Steatohepatitis|Fibrosis, Liver|Steatosis of Liver|Hepatocellular Carcinoma|Cardiovascular Diseases|Type 2 Diabetes|Dyslipidaemia|Hypertension|Obesity|Other Associated Comorbidities",,"June 22, 2020","Universitair Ziekenhuis Antwerpen, Antwerp, Belgium|Helsinki University Hospital, Helsinki, Finland|Le Centre de Recherche Clinique (CRC) du CHU d'Angers, Angers, France|Institut ICAN - Institute of Cardiometabolism And Nutrition Hôpital de la Pitié Salpêtrière, Paris, France|UNIVERSITÄTSKLINIKUM der RWTH Aachen, Aachen, Germany|Charité University Hospital Berlin, Berlin, Germany|Universitätsklinikum Freiburg, Freiburg, Germany|UNIVERSITÄTSMEDIZIN der Johannes Gutenberg Universität Mainz, Mainz, Germany|Universitätsklinikums Würzburg, Würzburg, Germany|Laiko General Hospital of Athens, Athens, Greece|Polytechnic University of Marche, Ancona, Italy|Università degli Studi Milano, Milan, Italy|Università di Palermo, Palermo, Italy|Università Cattolica del Sacro Cuore, Rome, Italy|Department of Medical Sciences University of Torino, Turin, Italy|Amsterdam UMC, Amsterdam, Netherlands|Hospital de Santa Maria, Lisboa, Portugal|Vall d'Hebron University Hospital, Barcelona, Spain|Biodonostia Health Research Institute, Donostia, Spain|Puerta de Hierro University Hospital, Majadahonda, Spain|Marqués de Valdecilla University Hospital, Santander, Spain|Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocío University Hospital, Sevilla, Spain|HU Clínico de Valladolid, Valladolid, Spain|Karolinska Universitetssjukhuset, Huddinge, Sweden|Linköping University Hospital, Linköping, Sweden|Inselspital, University Hospital, Bern, Switzerland|University Hospitals Birmingham Nhs Foundation Trust, Birmingham, United Kingdom|Addenbrooke'S Hospital, Cambridge, United Kingdom|Queen Elizabeth Hospital, Gateshead, United Kingdom|Hull Royal Infirmary, Hull, United Kingdom|Royal London Hospital, Barts Health NHS Trust, London, United Kingdom|St George's University Hospitals, London, United Kingdom|The Newcastle Upon Tyne Hospitals Nhs Foundation Trust, Newcastle-upon Tyne, United Kingdom|Queen'S Medical Centre, Nottingham, United Kingdom|Oxford University Hospitals Nhs Foundation Trust, Oxford, United Kingdom|Derriford Hospital, Plymouth, United Kingdom|Queen Alexandra Hospital, Portsmouth, United Kingdom","https://ClinicalTrials.gov/show/NCT04442334"
228,"NCT04217759","Healthy Lifestyle Intervention on Diabetes Risk Reduction Among Bruneian Young Adults","Completed","No Results Available","Overweight and Obesity|Risk Reduction|Diabetes Mellitus, Type 2","Behavioral: Healthy lifestyle intervention","January 3, 2020","PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Brunei, Bandar Seri Begawan, Brunei Darussalam","https://ClinicalTrials.gov/show/NCT04217759"
229,"NCT04232995","Balance Training in Diabetic Neuropathy","Recruiting","No Results Available","Diabetic Neuropathy With Neurologic Complication","Other: Balance Training|Other: General Exercises","January 18, 2020","Institute of Physical Medicine and Rehabilitation, Dow University of Health Sciences, Karachi, Sindh, Pakistan","https://ClinicalTrials.gov/show/NCT04232995"
230,"NCT04419948","Oleocanthal Rich Olive Oil Acute Effects on Hyperglycemia and Platelet Activation in T2DM","Recruiting","No Results Available","Diabetes Mellitus, Adult-Onset|Platelet Dysfunction|Postprandial Hyperglycemia|Lipidemia|Inflammation|Oxidative Stress","Other: White bread|Other: Butter|Other: Refined olive oil|Other: EVOO with 250 mg/kg oleocanthal|Other: EVOO with 500 mg/kg oleocanthal|Other: Ibuprofen","June 9, 2020","Department of Nutrition and Dietetics, Harokopio University, Athens, I Am Not In The U.S. Or Canada, Greece","https://ClinicalTrials.gov/show/NCT04419948"
231,"NCT04285554","Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Device: iRF System Hepatic Denervation","February 26, 2020","Cardiology, P.C., Birmingham, Alabama, United States|Stanford University Medical Center, Stanford, California, United States|AdventHealth Translational Research Institute, Orlando, Florida, United States|Prairie Education & Research Cooperative (PERC), Springfield, Illinois, United States|Mercy Hospital, Coon Rapids, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04285554"
232,"NCT04285450","The Clinical Effect of Vitamin K Administration in Type 2 Diabetic Patients","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Dietary Supplement: Vitamin K|Other: Placebo","February 26, 2020","Kasr Al Aini Hospital, Cairo, Egypt","https://ClinicalTrials.gov/show/NCT04285450"
233,"NCT04308590","Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas","Recruiting","No Results Available","Hypercortisolism","Drug: relacorilant|Other: placebo","March 16, 2020","Site 01, Wilmington, North Carolina, United States|Site 02, Summerville, South Carolina, United States|Site 03, El Paso, Texas, United States|Site 05, Fort Worth, Texas, United States|Site 04, Shavano Park, Texas, United States","https://ClinicalTrials.gov/show/NCT04308590"
234,"NCT04373265","Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production","Not yet recruiting","No Results Available","Adrenocortical Carcinoma","Drug: Relacorilant|Drug: Pembrolizumab","May 4, 2020",,"https://ClinicalTrials.gov/show/NCT04373265"
235,"NCT04244110","Pilot for the Analysis of Usability in the Use of the Diacare Platform for People With Type 2 DM and Their Professionals","Active, not recruiting","No Results Available","Diabetes Mellitus, Type 2",,"January 28, 2020","CAP Bellvitge, Hospitalet de Llobregat, Barcelona, Spain","https://ClinicalTrials.gov/show/NCT04244110"
236,"NCT04380844","Effects of an Activity Control System in Patients With Diabetes: a Randomized Controlled Trial","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Other: Beprevent","May 8, 2020",,"https://ClinicalTrials.gov/show/NCT04380844"
237,"NCT04269655","Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Device: Cloud-Based Continuous Glucose Monitoring","February 17, 2020","Scripps Whittier Diabetes Institute, La Jolla, California, United States","https://ClinicalTrials.gov/show/NCT04269655"
238,"NCT04227379","Diabetes Disparities: Texting to Extend Treatment (DD-TXT)","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Behavioral: Intervention 1- DD-TXT|Behavioral: Comparison - DSE","January 13, 2020","North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida, United States|Jesse Brown VA Medical Center, Chicago, IL, Chicago, Illinois, United States|Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, Bedford, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04227379"
239,"NCT04260100","Diabetic Care Self-Management Mobile Health Application Among Diabetes Mellitus Clients in Malaysia","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Behavioral: Diabetes Care Self-Management Mobile Health Application","February 7, 2020","Klinik Kesihatan UTC Kangar, Kangar, Perlis Indera Kayangan, Malaysia","https://ClinicalTrials.gov/show/NCT04260100"
240,"NCT04264572","Project MiNT: Assessing the Impact of Food & Video-Based Nutrition Education on Patients With Poorly Controlled Diabetes","Recruiting","No Results Available","Diabetes Mellitus, Type 2","Other: Medically Tailored Meals|Behavioral: Tele-Medical Nutrition Therapy (tele-MNT)","February 11, 2020","Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04264572"
241,"NCT04295005","A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Empagliflozin|Drug: DPP-4i|Drug: Sitagliptin|Drug: GLP-1-RA","March 4, 2020",,"https://ClinicalTrials.gov/show/NCT04295005"
242,"NCT04354740","Predictors of Coronary Revascularization Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2 With Acute Coronary Syndrom","Procedure: with percutaneous coronary intervention (PCI) are with new-generation drug-eluting stents (DES)","April 21, 2020",,"https://ClinicalTrials.gov/show/NCT04354740"
243,"NCT04340908","Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|Cardiac Surgery","Drug: Dapagliflozin 10 MG|Drug: Placebos","April 10, 2020","Beijing Anzhen Hospital, Capital Mediacal University, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT04340908"
244,"NCT04215328","Facilitated Release of Endogenous Enterokines","Completed","No Results Available","Diabetes Mellitus, Type 2","Dietary Supplement: Mixed-Meal|Dietary Supplement: Electrolyte Solution","January 2, 2020","Roybal Diabetes Management Clinic, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT04215328"
245,"NCT04332302","Power Strength Training in Type 2 Diabetic Mellitus Older Adults","Enrolling by invitation","No Results Available","Diabetes Mellitus, Type 2|Frailty","Other: Power resistance training","April 2, 2020","Instituto Nacional de Educación Física, Madrid, Spain","https://ClinicalTrials.gov/show/NCT04332302"
246,"NCT04420845","Diabetes Self-Management Education With Sleep Hygiene","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|Sleep Hygiene","Behavioral: Diabetes Self-Management and Support (DSMES) and Sleep Hygiene Education and Support (SHES)","June 9, 2020","University of Arkansas for Medical Sciences Northwest, Fayetteville, Arkansas, United States","https://ClinicalTrials.gov/show/NCT04420845"
247,"NCT04413578","CGM - Reimagine Primary Care","Completed","No Results Available","Diabetes Mellitus, Type 2","Device: Dexcom G6|Device: Contour NextOne","June 4, 2020","Holladay Internal Medicine, Holladay, Utah, United States|Intermountain Cottonwood Family Practice, Murray, Utah, United States|Intermountain Senior Clinic, Murray, Utah, United States|Avenues Internal Medicine, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT04413578"
248,"NCT04357392","Effect of Glucocorticoid on Exogenous Insulin Antibody Syndrome","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: Prednisone","April 22, 2020",,"https://ClinicalTrials.gov/show/NCT04357392"
249,"NCT04354090","Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09","Completed","No Results Available","Diabetes Mellitus, Type 2","Drug: JY09","April 21, 2020","Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China","https://ClinicalTrials.gov/show/NCT04354090"
250,"NCT04334109","Comparative Effectiveness of Family DSMES and Standard DSMES Among Diverse Populations","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Behavioral: Family Diabetes Self-Management Education and Support|Behavioral: Standard Diabetes Self-Management Education and Support","April 6, 2020","University of Arkansas for Medical Sciences Northwest, Fayetteville, Arkansas, United States","https://ClinicalTrials.gov/show/NCT04334109"
251,"NCT04260438","Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Drug: CKD-501 0.5mg Tab. 1T, D759 100mg Tab. 1T and D150 1000mg Tab. 1T|Drug: CKD-393 0.5/100/1000mg formulation 1 Tab. 1T|Drug: CKD-393 0.5/100/1000mg formulation 2 Tab. 1T","February 7, 2020","Korea University Anam Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04260438"
252,"NCT04253431","The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus","Completed","No Results Available","Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2","Device: Droplet lancing device (HTL-Strefa S.A.)|Device: Microlet 2 lancing device (Bayer)|Device: OneTouch Delicia lancing device (LifeScan)|Device: ReliOn lancing device (ReliOn)|Device: Accu-Chek Softclix lancing device (Roche)|Device: BGStar lancing device (Sanofi Aventis)|Device: Ultra-Fine 33G lancets (BD)|Device: Droplet 33G lancets (HTL-Strefa S.A.)|Device: OneTouch Delicia Extra Fine 33G lancets (LifeScan)|Device: HaemoFine 33G lancets (HTL-Strefa S.A.)|Device: Softclix 28 G lancets (Roche)|Device: ReliOn Ultra-Thin Plus 33G lancets (ReliOn)|Device: GlucoJect Dual S lancing device (Menarini)|Device: Microlet 28G lancets (Bayer)|Device: BGStar Ultra-Thin 33G lancets (Sanofi Aventis)","February 5, 2020",,"https://ClinicalTrials.gov/show/NCT04253431"
253,"NCT04379427","Measurement Algorithm Control and Optimization With Subsequent Performance Evaluation of Sanmina Non-invasive Biosensors During a Standardized Meal Test in Patients With Diabetes Mellitus Type 1 and Type 2","Completed","No Results Available","Diabetes Mellitus","Device: Sanmina Biosensor","May 7, 2020","Pfuetzner Science & Health Institute GmbH, Mainz, Rhineland-Palatinate, Germany","https://ClinicalTrials.gov/show/NCT04379427"
254,"NCT04278742","A Collaborative Approach in Diabetes Foot Education - A Pragmatic Randomised Control Trial","Active, not recruiting","No Results Available","Diabetes Mellitus, Type 2|Neuropathy;Peripheral","Other: Patient education","February 20, 2020","Singapore General Hospital, Singapore, Singapore","https://ClinicalTrials.gov/show/NCT04278742"
255,"NCT04436900","Evaluation of Macular Structural and Functional Function Following Extensive Retinal Laser Therapy in Patients With Proliferative Diabetic Retinopathy","Completed","No Results Available","Diabetes Mellitus, Type 2","Procedure: Panretinal Photocoagulation (PRP)","June 18, 2020","Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran, Islamic Republic of","https://ClinicalTrials.gov/show/NCT04436900"
256,"NCT04304261","Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)","Recruiting","No Results Available","Diabetes Mellitus, Type 2|Cognitive Functions Confusion","Drug: Dapagliflozin|Drug: Metformin","March 11, 2020","The third hospital affiliated to the Army Medical University, Chongqing, Chongqing, China|Zhiming Zhu, Chongqing, Chongqing, China","https://ClinicalTrials.gov/show/NCT04304261"
257,"NCT04261738","Effects of HBO on Patients With DM","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1","Device: Hyperbaric Oxygen","February 10, 2020",,"https://ClinicalTrials.gov/show/NCT04261738"
258,"NCT04410419","Carbohydrate Loading and Diabetes in Colorectal Surgery","Active, not recruiting","No Results Available","Diabetes Mellitus, Type 2|Surgery|Surgery--Complications","Dietary Supplement: Pre-operative carbohydrate drink","June 1, 2020","University of Alberta Hospital, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT04410419"
259,"NCT04322240","Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy","Not yet recruiting","No Results Available","Diabetic Polyneuropathy|Diabetes Mellitus, Type 2","Drug: Alpha lipoic acid","March 26, 2020","Benha University Hospital, Banhā, Qalubiya, Egypt","https://ClinicalTrials.gov/show/NCT04322240"
260,"NCT04344210","Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus","Enrolling by invitation","No Results Available","COVID|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1","Behavioral: Tele-interventions related to diabetes management and mental well-being","April 14, 2020","Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil","https://ClinicalTrials.gov/show/NCT04344210"
261,"NCT04291391","The Alberta NutrIMM Study - Nutrition and Immunity","Recruiting","No Results Available","Diabetes Mellitus, Type 2|Obesity","Other: North American Diet","March 2, 2020","University of Alberta, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT04291391"
262,"NCT04217369","Impacts of Glucose Forecasting","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2","Device: Diabits Predictions","January 3, 2020",,"https://ClinicalTrials.gov/show/NCT04217369"
263,"NCT04313803","CGM in Utah Valley","Not yet recruiting","No Results Available","Diabetes Mellitus|Diabetes Mellitus, Type 2|Diabetes","Device: CGM","March 18, 2020",,"https://ClinicalTrials.gov/show/NCT04313803"
264,"NCT04406402","L-arginine and Asymmetric Dimethylarginine (ADMA) and Lifestyle Protocols","Completed","No Results Available","Diabetes Mellitus, Type 2|Obesity|Arginine|Asymmetric Dimethylarginine","Behavioral: Acute dietary protocols and lifestyle modification","May 28, 2020","Diabetes Unit, E. Wolfson Medical Center, Holon, Israel","https://ClinicalTrials.gov/show/NCT04406402"
265,"NCT04265261","A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy","Recruiting","No Results Available","Diabetic Retinopathy","Drug: Placebo|Drug: RG7774","February 11, 2020","Arizona Retina and Vitreous Consultants, Phoenix, Arizona, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States|Retina Group of New England, Waterford, Connecticut, United States|Rand Eye, Deerfield Beach, Florida, United States|Florida Retina Consultants, Lakeland, Florida, United States|Florida Eye Associates, Melbourne, Florida, United States|Medeye Associates, Miami, Florida, United States|Retina Vitreous Assoc of FL, Saint Petersburg, Florida, United States|Southeast Retina Center, Augusta, Georgia, United States|Marietta Eye Clinic, Marietta, Georgia, United States|University Retina and Macula Associates, PC, Oak Forest, Illinois, United States|Cumberland Valley Retina PC, Hagerstown, Maryland, United States|University of Michigan, Kellogg Eye Center, Ann Arbor, Michigan, United States|Deep Blue Retina PLLC, Southaven, Mississippi, United States|Sierra Eye Associates, Reno, Nevada, United States|Retina Center of New Jersey, Bloomfield, New Jersey, United States|Eye Associates of New Mexico, Albuquerque, New Mexico, United States|Charlotte Eye Ear Nose and Throat Associates, Charlotte, North Carolina, United States|Charleston Neuroscience Institute, Ladson, South Carolina, United States|Southeastern Retina Associates Chattanooga, Chattanooga, Tennessee, United States|Charles Retina Institute, Germantown, Tennessee, United States|Retina Res Institute of Texas, Abilene, Texas, United States|Retina Research Center, Austin, Texas, United States|Retinal Consultants of Houston, The Woodlands, Texas, United States|Strategic Clinical Research Group, LLC, Willow Park, Texas, United States|Emanuelli Research and Development Center LLC, Arecibo, Puerto Rico|Klinika Oftalmológie LFUK a UNB, Bratislava, Slovakia|Očná klinika UNB a SZU, Bratislava, Slovakia|Fakultna nemocnica Trencin, Trencin, Slovakia|Fakultna nemocnica s poliklinikou Zilina; Ocne oddelenie, Zilina, Slovakia|Hospital Universitari de Bellvitge; Servicio de Oftalmologia, Hospitalet De Llobregat, Barcelona, Spain|Hospital General de Catalunya, San Cugat Del Valles, Barcelona, Spain|Hospital Universitario Puerta de Hierro; Servicio de oftalmologia, Majadahonda, Madrid, Spain|Clinica Oftalvist Valencia, Burjassot, Valencia, Spain|Clinica Barraquer, Barcelona, Spain|Hospital Dos de Maig, Barcelona, Spain|Hosp Clinic y Provincial de Barcelona, Barcelona, Spain|Pio del Rio Hortega University Hospital, Valladolid, Spain|Miguel Servet University Hospital, Zaragoza, Spain|Royal Victoria Hospital; Outpatients Department, Belfast, United Kingdom|Colchester General Hospital, Colchester, Essex, United Kingdom|Royal Surrey County Hospital, Guilford, United Kingdom|Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom|Royal Liverpool University Hospital, Liverpool, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom","https://ClinicalTrials.gov/show/NCT04265261"
266,"NCT04365517","The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients","Not yet recruiting","No Results Available","Covid19|Diabetes Mellitus, Type 2|CKD","Drug: Sitagliptin","April 28, 2020","ASST FBF Sacco, Milan, Italy","https://ClinicalTrials.gov/show/NCT04365517"
267,"NCT04263376","Bariatric Surgery-Induced Shift in Gut Microbiome and NAFLD","Enrolling by invitation","No Results Available","Obesity|Diabetes Mellitus, Type 2|NAFLD",,"February 10, 2020","Cleveland Clinic Foundation, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT04263376"
268,"NCT04336800","Multi-Parametric MRI Assessment of the Liver in Diabetic Volunteers (Partners Registry)","Not yet recruiting","No Results Available","Non-Alcoholic Fatty Liver Disease|Diabetes Mellitus, Type 2","Device: LiverMultiscan","April 7, 2020",,"https://ClinicalTrials.gov/show/NCT04336800"
269,"NCT04259801","First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes","Active, not recruiting","No Results Available","Healthy Volunteers|Overweight|Obesity|Diabetes Mellitus, Type 2","Drug: NNC0480-0389|Drug: Semaglutide|Drug: Placebo (NNC0480-0389)|Drug: Placebo (semaglutide)","February 6, 2020","Novo Nordisk Investigational Site, Groningen, Netherlands","https://ClinicalTrials.gov/show/NCT04259801"
270,"NCT04229667","Community Models for Hypertension and Diabetes Care for Refugees","Not yet recruiting","No Results Available","Hypertension|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Comorbidities and Coexisting Conditions","Other: Improved Community Health Volunteer (CHV) program","January 18, 2020","International Rescue Committee, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04229667"
271,"NCT04219514","Investigating Novel Predictions of Hypoglycemia Occurrence in Real-world Models","Active, not recruiting","No Results Available","Hypoglycemia|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1",,"January 7, 2020","Ipsos, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04219514"
272,"NCT04340648","Measurement Algorithm Control, Optimization, and Performance Evaluation of the Vital USA GlucoseDetect","Completed","No Results Available","Diabetes Mellitus","Device: Vital GlucoseDetect","April 9, 2020","Pfützner Science & Health Institute GmbH, Mainz, Rhineland-Palatinate, Germany","https://ClinicalTrials.gov/show/NCT04340648"
